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Abstract 1 
Until recently, microbial identification in clinical diagnostic laboratories has mainly relied on 2 
conventional phenotypic and gene sequencing identification techniques. The development of 3 
Matrix-Assisted Laser Desorption Ionization Time-Of-Flight mass spectrometry (MALDI-4 
TOF MS) devices has revolutionized the routine identification of microorganisms in clinical 5 
microbiology laboratories by introducing an easy, rapid, high throughput, low-cost and 6 
efficient identification technique. This technology has been adapted to the constraint of 7 
clinical diagnostic laboratories and has the potential to replace and/or complement 8 
conventional identification techniques for both bacterial and fungal strains. Using 9 
standardized procedures, the resolution of MALDI-TOF MS allows accurate identification at 10 
the species level of most Gram-positive and Gram-negative bacterial strains with the 11 
exception of a few difficult strains that require more attention and further development of the 12 
13 
and much quicker than conventional techniques. Recent studies have shown that MALDI-14 
TOF MS has also the potential to accurately identify filamentous fungi and dermatophytes, 15 
providing that specific standardized procedures are established for these microorganisms. 16 
Moreover, MALDI-TOF MS has been used successfully for microbial typing and 17 
identification at the subspecies level, demonstrating that this technology is a potential efficient 18 
tool for epidemiological studies and for taxonomical classification.19 
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1 
Introduction 2 
The Matrix-Assisted Laser Desorption Ionization Time-Of-Flight mass spectrometry 3 
(MALDI-TOF MS) is a rapid, accurate and cost-effective method of microbial 4 
characterization and identification. This technology generates characteristic mass spectral 5 
fingerprints, that are unique signatures for each microorganism and are thus ideal for an 6 
accurate microbial identification at the genus and species levels, and has a potential to be used 7 
for strain typing and identification. 8 
Mass spectrometry has been used for several decades in chemistry but it was in 1975 that 9 
Anhalt and Fenselau (Anhalt & Fenselau, 1975) proposed for the first time that bacterial 10 
characterization could be achieved using this technique. They noticed that unique mass 11 
spectra were produced from bacterial extracts of different genera and of different species.  In 12 
the 1980s, the development of desorption/ionization techniques such as plasma desorption 13 
(PD), laser desorption (LD) and fast atom bombardment (FAB) allowed the generation of 14 
molecular biomarker ions from microorganisms leading to bacterial profiling (Heller, et al., 15 
1987, Platt, et al., 1988).  In early experiments, only biomarker molecules of low mass 16 
molecular masses such as bacterial lipids were analysed (Shah & Collins, 1980, Heller, et al., 17 
1988) since the processes used for the ionization of biomolecules were too energy rich to 18 
avoid unpredictable analyte decomposition. The evolution of soft ionization techniques such 19 
as matrix-assisted laser desorption ionization (MALDI) and electrospray ionization (ESI) 20 
developed in the late 1980s (Tanaka & Fenn, 2002) made possible analysis by mass 21 
spectrometry of large biomolecules such as intact proteins. Several groups (Cain, et al., 1994, 22 
Girault, et al., 1996, Liang, et al., 1996) demonstrated that MALDI-TOF could be used to 23 
produce protein profiles following cellular extraction and purification. However, Holland et 24 
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4 
al. (Holland, et al., 1996) reported for the first time in 1996 that MALDI-TOF spectral 1 
fingerprints could be obtained from whole bacterial cells without pre-treatment before the MS 2 
analysis. This approach was then used to identify bacteria at the genus and species levels by 3 
multiple research teams (Claydon, et al., 1996, Krishnamurthy & Ross, 1996, Haag, et al., 4 
1998, Pribil & Fenselau, 2005, Pignone, et al., 2006, Vargha, et al., 2006). Since the late 5 
1990s, the success of this technique for the rapid identification of bacteria but also fungi and 6 
yeast was demonstrated by an impressive exponential increase in the number of publications 7 
concerning MALDI-TOF identification of microorganisms. 8 
MALDI-TOF MS has been used to characterize a wide variety of microorganisms including 9 
bacteria, fungi, and viruses (Giebel, et al., 2010).  The capability of MALDI-TOF to rapidly 10 
characterize microorganisms favours its potential applications in multiple areas including 11 
medical diagnostics, biodefense, environmental monitoring, and food quality control. 12 
MALDI-TOF MS is suitable for high-throughput and rapid microbial identification at low 13 
costs and is an alternative for conventional laboratory biochemical and molecular 14 
identification systems. 15 
In this review, we will first present the technical background of the MALDI-TOF MS method 16 
including sample preparation, mass spectrometry, bioinformatics analysis of fingerprint 17 
spectra and their comparison with databases for microorganism identification. We will then 18 
present the application of MALDI-TOF MS microbial identification from bacteria and fungi 19 
isolates and directly from clinical samples. We will then address the important issues of 20 
quality control, maintenance, time-to results and cost effectiveness. Finally, we will discuss 21 
the use of MALDI-TOF MS for additional applications such as microbial taxonomy, typing 22 
and identification of virulence factors (Bizzini & Greub, 2010, Murray, 2010). 23 
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5 
Technique 1 
A mass spectrometer is composed of three functional units, (1) an ion source to ionize and 2 
transfer sample molecules ions into a gas phase, (2) a mass analyser that separate ions 3 
according to their mass-to-charge ratio (m/z), and (3) a detection device to monitor separated 4 
ions. Several ionization methods have been developed including PD, FAB, chemical 5 
ionization (CI), atmospheric pressure chemical ionization (APCI), electrospray (ESI), LD, and 6 
matrix-assisted laser desorption/ionisation (MALDI). The method of ionization is determined 7 
according to the nature of the sample and the goal of the MS analysis, but ESI and MALDI 8 
are soft ionization techniques that allow ionization and vaporization of large non-volatile 9 
biomolecules such as intact proteins (Emonet, et al., 2010). In contrary to ESI, MALDI 10 
generates mostly singly charged ions and thus MALDI derived spectra may include larger 11 
numbers of proteins. Laser desorption has been successfully coupled to several kinds of mass 12 
analysers to characterize microorganisms such as time of flight (TOF) (Lay, 2001), Fourier 13 
transform ion cyclotron resonance (Ho & Fenselau, 1998), quadrupole-TOF (She, et al., 2001) 14 
and quadrupole ion trap (Meetani, et al., 2007).  The various operative modes of the different 15 
mass analysers confer strengths and weaknesses in their performance characterized by mass 16 
accuracy, resolution, mass range, sensitivity, scan speed and cost (Table S1) (Jonsson, 2001, 
17 
Aebersold & Mann, 2003, Domon & Aebersold, 2006, Graham, et al., 2007). The 
18 
performance of mass analysers can be improved by combining and/or summing the 19 
advantages of one sort of analyser (tandem MS) or of different analysers (hybrid MS) through 20 
the development of multistage instruments such as hybrid quadrupole time of flight (Q-Q-21 
TOF), tandem time of flight (TOF-TOF) and triple quadrupole (Domon & Aebersold, 2006). 22 
Overall, the required performance expected form a mass analyser depends on the type of 23 
sample to be analysed (complex/simple mixtures, proteins, peptides, lipids, polysaccharides) 24 
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6 
and the ultimate goal of the analysis (quantification, protein identification, microorganism 1 
identification, biotyping).  2 
Time of flight mass analysers (Cotter, 1997) have been used for intact microorganisms 3 
detection for many years (Heller, et al., 1987) because they are suited for interfacing with 4 
pulse laser ionization and offer the possibility of rapid analysis and miniaturization.  5 
In MALDI analysis, samples are prepared by mixing the samples with a matrix which results 6 
in the crystallisation of the sample within the matrix. The matrix is composed of small acid 7 
molecules that have a strong optical absorption in the range of the laser wavelength used. The 8 
matrix composition varies according to the biomolecule to be analysed and the type of laser 9 
used (Fenselau & Demirev, 2001). The most frequently used matrices are 2,5-10 
dihydroxybenzoic acid (DHB), α-cyano-4-hydroxycinnamic acid (CHCA), sinapinic acid 11 
(SA), ferulic acid (FA) and 2,4-hydroxy-phenyl benzoic acid (HPBA). Ferulic acid, sinapinic 12 
acid and CHCA have been shown to be effective for the detection of proteins biomarkers 13 
(Fenselau & Demirev, 2001, Vaidyanathan, et al., 2002, Williams, et al., 2003) whereas DHB 14 
appears to be the best choice for the detection of glycopeptides and glycoproteins (Giebel, et 15 
al., 2010). The size and the intensities of the peaks of the detected molecules are dependent on 16 
the matrix selected for the experiment. DHB and CHCA are usually optimal for the detection 17 
of lower mass ions (Hathout, et al., 2000, Williams, et al., 2003, Ruelle, et al., 2004) with a 18 
detection up to 10kDa when the proper solvent is used. Both SA and FA have been shown to 19 
be better for the detection of higher mass ions (above 15kDa) (Madonna, et al., 2000, 20 
Conway, et al., 2001, Ruelle, et al., 2004, Vargha, et al., 2006) but provide a lower sensitivity 21 
than CHCA (Wang, et al., 1998, Ruelle, et al., 2004).  22 
Intact microorganisms can be directly processed to MALDI-TOF without pre-treatment 23 
because most vegetative bacteria are lysed following exposure to water, organic solvent 24 
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7 
and/or strong acid in the MALDI matrix. When resistant microrganims such as some viruses, 1 
bacterial spores and yeast cells have to be analysed by MALDI, strong organic acids and/or 2 
alcohols are usually added in pre-treatment steps. Similarly, for some bacterial species (such 3 
as the Actinomyces), specific pre-treatment or protein extraction procedures may be useful 4 
(Bizzini, et al., 2011). 5 
The marked differences in bioanalytes fingerprints observed with the different matrix 6 
demonstrate that similar standardized preanalytical and analytical procedures than those 7 
performed to establish a database must be followed to ensure accurate identification. This 8 
implies that any modification of the procedure (i) should conformed to the manufacturer’s 9 
recommendations, (ii) should be analysed to demonstrate that protein profiles remained 10 
consistent with database fingerprints or (iii) should use a new database created with the 11 
modified protocol. 12 
In practice, a microbial sample is mixed with a matrix on a conductive metal plate. The 13 
mixture can be deposited on the metal support or alternatively the microbial sample is 14 
deposited and dried out on the support before the addition of the matrix. After the 15 
crystallisation of the matrix and compound, the target on the metal plate is introduced in the 16 
mass spectrometer where it is bombarded with brief laser pulses from usually a nitrogen laser 17 
(Figure 1). The matrix absorbs energy from the laser leading to the desorption of the analytes 18 
that are then vaporised and ionized in the gas phase. This matrix-assisted desorption and 19 
ionization of the analytes leads to the formation of predominantly singly charged sample ions. 20 
The desorbed and ionized molecules are first accelerated through an electrostatic field and are 21 
then ejected through a metal flight tube that is subjected to a vacuum until they reach a 22 
detector, with smaller ions travelling faster than larger ions. The time of flight required to 23 
reach the detector is dependent on the mass (m) and charge (z) of the bioanalyte and is 24 
proportional to the square root of m/z. Thus, bioanalytes with different m/z that composed a 25 
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8 
complex sample are separated according to their time of flight (TOF) and create a mass 1 
spectrum that is characterized by both the m/z and the intensity of the ions, which is the 2 
number of ions of a particular m/z that struck the detector. The results of a spectral signature 3 
is composed of spikes ranging usually from 1000 to 20’000 m/z. Usually, MALDI produces 4 
single charged (z=1) ions and thus the m/z of an analyte corresponds to the value of its mass. 5 
Data analysis 6 
Biomarkers 7 
Several research groups have demonstrated that biomolecules desorbed from whole 8 
unfractionated cells and detected above 4 kDa are intact proteins (Arnold, et al., 1999, Dai, et 9 
al., 1999, Holland, et al., 1999, Ryzhov & Fenselau, 2001).  Most of the biomarkers detected 10 
in MALDI-TOF spectra of intact bacterial cells have a molecular mass below 15kDa. A 11 
thorough characterization of MALDI biomarkers performed on intact Escherichia coli cells 12 
have demonstrated that the MALDI detected biomolecules corresponds to proteins from the 13 
inside of bacterial cell that are abundant, basic and of medium hydrophobicity (Ryzhov & 14 
Fenselau, 2001). Among these MALDI-detected proteins, about half matched ribosomal 15 
proteins that are abundant and very basic (Arnold, et al., 1999, Ryzhov & Fenselau, 2001), 16 
which is a biochemical trait favourable for efficient ionization during the MALDI process 17 
(Krause, et al., 1999). Thus, the abundance (more than 20% of total cell proteins) and the 18 
basic nature of ribosomal proteins explain why the majority of the peaks detected in a 19 
MALDI-TOF spectrum correspond to ribosomal proteins. In addition, the lysis of bacterial 20 
cells in organic solvents and in acidic conditions favouring the extraction of ribosomal 21 
proteins combined with the utilisation of a specific matrix allowed the development of a 22 
method leading to the ionization of mainly ribosomal proteins (Suh & Limbach, 2004).  23 
In a study performed by Ryzhov et al. on E. coli to characterize the nature of the proteins 24 
favoured by MALDI, several additional group of proteins than ribosomal proteins were 25 
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9 
identified (Ryzhov & Fenselau, 2001). These also included abundant nucleic acid-binding 1 
protein, such as E. coli DNA-binding protein HU α- and β-subunits (DbhA and DbhB, 2 
respectively) and cold-shock proteins, such as cold-shock proteins A, C and E (CspA, CspC, 3 
CspE). Similar to ribosomal proteins, these protein families are highly abundant, basic and of 4 
medium hydrophobicity. Holland et al. potentially identified the acid-resistant precursor 5 
proteins HdeA and HdeB observed in the MALDI analysis of both intact E. coli and Shigella 6 
flexneri (Holland, et al., 1999).  The ion at m/z 7643 in the spectra from Pseudomonas 7 
aeruginosa was mapped to the cold-shock protein CspA and similarly the ion at m/z 7684 8 
observed in P. putida was  identified as the cold-acclimation protein CapB (Fenselau & 9 
Demirev, 2001). Sun et al. have selected in the MALDI-TOF spectra of Lactobacillus 10 
plantarum 34 reliable biomarkers including 31 ribosomal subunit proteins and 3 ribosome 11 
associated proteins identified as a small heat shock protein, a methylase and the DNA-binding 12 
protein II (Sun, et al., 2006). A comprehensive study was published by Dieckmann et al. 13 
where protein identities were assigned to biomarker peaks obtained by whole-cell MALDI-14 
TOF MS of salmonellae (Dieckmann, et al., 2008).  Most of the proteins identified in this 15 
study were abundant cytosolic proteins that were highly basic including in particular 16 
ribosomal proteins, proteins involved in DNA or RNA binding, and other abundant proteins, 17 
most of which having a high isoelectric point greater than 9. Thus, examples of biomarker 18 
peaks assigned to proteins characterized by a high isoelectric point included not only 19 
ribosomal proteins but also many other proteins such as cold shock-like protein CspH, 20 
translation initiation factor IF-1 (pI 9.23), DNA binding protein HU α- and β- (pI 9.69 and 21 
9.57), the ribosome modulation factor (pI 10.56), and integration host factors A and B (both 22 
pI 9.34). Lower pI values proteins detected in this study were in general very abundant 23 
proteins including the nucleoid-associated protein H-NS (pI 5.32), the RNA chaperone CspE 24 
(pI 8.08), glutaredoxin-1 (pI 5.63) and the phosphocarrier protein HPr (pI 5.6). 25 
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10 
Thus, most of MALDI-TOF spectra are composed of very conserved proteins with house-1 
keeping functions affected to a minimal extent by environmental conditions and thus 2 
considered to be optimal for routine identification of bacteria. 3 
Biomarkers Reproducibility 4 
The reproducibility of MALDI-TOF spectrum of whole bacterial sample is problematic since 5 
large variations can be seen in spectra of the same bacterial species obtained in different 6 
conditions. Many experimental parameters can have an important effect on the observed mass 7 
spectra (Wang, et al., 1998). The reproducibility is dependent on the MALDI-TOF 8 
instrument, the matrix used, the age of the microorganism, the sample:matrix ratio, the sample 9 
concentration, the culture medium and growth conditions (Valentine, et al., 2005). However, 10 
several studies have shown that a subset of peaks from genetically identical bacteria was 11 
conserved in spectra obtained in different experimental conditions (Wang, et al., 1998, 12 
Welham, et al., 1998). These conserved peaks, among which ribosomal proteins are well 13 
represented, explain the feasibility to use MALDI-TOF for bacterial identification even 14 
without the standardization of experimental conditions. These results also suggest that 15 
selected specific conserved biomarker proteins could be used for bacterial identification 16 
irrespective of changes in other biomarkers. However, to optimize the reproducibility, a 17 
standardization of sample preparation (e.g. choice of matrix, concentrations, solvent and 18 
crystallization conditions) has to be established by diagnostic laboratories. 19 
Intra-laboratory reproducibility 20 
Only a few studies have reported investigations on intra-laboratory reproducibility. In two 21 
studies that were focusing only on the presence or absence of particular peaks but not on peak 22 
intensities, the level or reproducibility obtained was equal to 75% or higher using the same 23 
mass spectrometer and similar sample preparation techniques (Saenz, et al., 1999, Walker, et 24 
al., 2002). The reproducibility of MALDI-TOF MS fingerprints was high even when mass 25 
Page 10 of 73
ScholarOne Support 1-434/964-4100
FEMS Microbiology Reviews
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
11 
spectra were obtained from bacterial cultures propagated in the same standard culture 1 
conditions during weeks and even months (Bernardo, et al., 2002). 2 
In our laboratory, we observed that the reproducibility is mainly dependent on the quality of 3 
the deposit and that the extraction step is not associated with significant supplementary 4 
variability. Thus, when considering the higher peaks (>200 intensity units) obtained with E. 5 
coli strain ATCC 25922 in 10 independent analyses, 66 peaks were present in all 10 replicates 6 
performed with proteins obtained from the same extraction whereas 78 peaks were present in 7 
the 10 spectra obtained from 10 independent extractions (Figure 2A). Similar results were 8 
obtained with S. aureus strain ATCC 25923 (Figure 2B). 9 
Inter-laboratory reproducibility 10 
The variation of inter-laboratory reproducibility is not surprisingly much higher since small 11 
variation in sample preparation and analysis may significantly affect mass fingerprints. 12 
Unfortunately, only a few attempts have been made to compare results from different 13 
laboratories on the same organism. In addition, inter-laboratory studies based on different 14 
comparative settings have been performed and gave very different results. Studies comparing 15 
mass spectra of identical microorganisms obtained in different locations but with the same 16 
experimental protocols and instruments hardware and software have shown promising results 17 
in term of inter-laboratory reproducibility. For instance, two studies using different bacterial 18 
species have demonstrated that more than 60% of the peaks observed in mass spectra were 19 
similar in separate laboratories (Wang, et al., 1998, Walker, et al., 2002). However, a poor 20 
inter-laboratory reproducibility of MALDI-TOF MS of intact microorganisms was 21 
demonstrated in a study where three independent laboratories using three different 22 
commercial instruments performed a MALDI-TOF MS analysis of identical aliquots of E. coli 23 
culture prepared and analysed in the same experimental conditions (Wunschel, et al., 2005). 24 
In this study, only 25% of the biomarkers were found in common by all three laboratories and 25 
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12 
more than 50% of the peaks were detected in spectra from only one of the three laboratory. Of 1 
importance, when the mass spectra collected from the instrument of one of the laboratory was 2 
analysed in the other two laboratories, 70% of the mass fingerprints could be identified 3 
correctly as E. coli. This finding underlines the importance of the instrument in the 4 
establishment of bacterial fingerprint databases.  5 
Application for microorganism identifications 6 
Two general MALDI-TOF MS methods have been proposed to characterize microorganisms: 7 
(1) mass spectra comparison with fingerprints database and (2) matching of biomarker masses 8 
to a proteome database. In the first approach, generated unique spectra of intact cells are 9 
compared with previously collected fingerprint libraries that are commercially available. This 10 
solution is rapid, simple and is easily adaptable for routine use in diagnostic laboratories. This 11 
approach is convenient to develop specific databases constituted of unique and conserved 12 
peaks that can be used for species and subspecies identification, independently of the culture 13 
conditions used to grow the microorganism (Carbonnelle, et al., 2007). In the second 14 
approach, the biomarker masses associated with an unknown microorganism are identified by 15 
matching protein molecular masses in the spectrum with protein molecular masses predicted 16 
from sequenced genomes (Demirev, et al., 1999). This method is based on the observation 17 
that the majority of observed biomolecules above 4000 m/z in MALDI-TOF spectra of whole 18 
cell extracts are proteins. An available algorithm predicts protein masses in silico from the 19 
genomes and seeks matches with experimentally derived masses (Pineda, et al., 2000).  20 
However, this application is limited to microorganisms whose genomes are sequenced and 21 
further development in strategies for organization of the proteome database is required. The 22 
advantage of such a bioinformatics-based approach compared to bacterial fingerprinting is 23 
that the identification tolerates variations in the protein profiles and thus differences in culture 24 
growth and sample treatment conditions.  25 
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13 
Bacterial identification 1 
The identification of microorganisms in clinical diagnostic microbiology laboratories is 2 
nowadays mainly performed by analysis of biochemical reactions and phenotypic 3 
characteristics, such as growth on different media, colony morphology and Gram staining. 4 
When combined, these routine laboratory techniques ensure an accurate identification of most 5 
microorganisms but are costly, require time and need in some cases well-trained technician 6 
for correct interpretation. One of the major advantages of using MALDI-TOF technology for 7 
bacterial identification is the time-to-result, which is reduced from 24-48h to less than an 8 
hour. In addition, MALDI-TOF allowed accurate bacterial identification of a large variety of 9 
bacteria, that only exhibit few phenotypic traits and that were identified by 16S rRNA gene 10 
sequencing prior to the MALDI-TOF era (Bizzini, et al., 2011). 11 
Routine identification 12 
Several approaches are commonly used in routine diagnostic laboratories. One typical 13 
approach is to pick bacterial isolates colonies freshly grown on defined agar medium with a 14 
sterile tip and to smear a thin film onto a ground steel MALDI target plate. The microbial film 15 
is then overlaid with a MALDI matrix selected as recommended by the MALDI-TOF 16 
manufacturers, typically 1.5 µl CHCA in 50% acetonitrile/2.5% trifluoroacetic acid for the 17 
Bruker instrument and 0.5 µl of 20mg DHB dissolved in 1ml water-ethanol-acetonitrile 18 
[1:1:1] mix for the Shimadzu instrument. In our laboratory, to increase identification yield, we 19 
routinely add formic acid on smeared micro-organisms before adding the matrix. The sample-20 
matrix mixture is dried at room temperature and then introduced in the MALDI-TOF 21 
instrument for data acquisition. The data are processed by the associated softwares (see 22 
above) and the spectra are compared to reference libraries for bacterial identification. A 23 
protein extraction step using ethanol-acetonitrile is performed when direct application 24 
procedure failed. 25 
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Several studies have analysed the bacterial identification efficiency of these two instruments 1 
(Bruker and Shimadzu) with their respective software and databases (Table 1).  We will 2 
present here the results of (1) two intra-laboratory studies using the Bruker system (Seng, et 3 
al., 2009, van Veen, et al., 2010), (2) an intra-laboratory study evaluating the two instruments 4 
using the same microbial samples (Cherkaoui, et al., 2010), and (3) a large international 5 
interlaboratory study performed with the Bruker instrument  (Mellmann, et al., 2009).  6 
Using the Bruker system, 327 clinical isolates previously identified by conventional 7 
techniques were analysed by MALDI-TOF MS by Van Veen et al. The authors observed a 8 
95.1% correct identification at the genus level and a 85.6% at the species level (van Veen, et 9 
al., 2010). The same group performed a prospective validation study on 980 clinical isolates 10 
of bacteria and yeast that showed a 92.2% correct identification by MALDI-TOF, a 11 
performance significantly better than the 83.1% identification obtained with conventional 12 
biochemical systems. Correct species identification by MADLI-TOF MS was observed in 13 
97.7% of Enterobacteriaceae, 92% of nonfermentative Gram-negative bacteria, 94.3% of 14 
staphylococci, 84.8% of streptococci, 84% of bacteria of the HACCEK group (Haemophilus, 15 
Actinobacillus, Cardiobacterium, Capnocytophaga, Eikenella and Kingella) and 85.2% of 16 
yeasts. In this work, misidentification was clearly associated with insufficient spectra from 17 
suitable reference strains in the reference spectra database.   18 
Seng et al. have conducted a prospective routine MALDI-TOF MS identification analysis 19 
with the Bruker system on 1660 bacterial isolates in parallel with conventional phenotypic 20 
bacterial identification (Seng, et al., 2009). Discrepancies were resolved by 16S rRNA and 21 
rpoB gene sequencing.  They have shown that 95.4% of the isolates were correctly identified 22 
by MALDI-TOF MS among which 84.1% at the species level and 11.3% at the genus level 23 
only. Absence of identification (2.8% of isolates) and incorrect identification (1.7% of 24 
isolates) were mainly due to improper database entries. They have estimated that the MALDI-25 
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TOF identification required an average time of 6 minutes for an estimated 70-80 % reduced 1 
cost compared to conventional methods of identification. 2 
Cherkaoui et al. have evaluated the two main MALDI-TOF MS systems, Bruker and 3 
Shimatzu, in a comparative study with 720 bacterial isolates under routine clinical laboratory 4 
conditions (Cherkaoui, et al., 2010). The isolates were analysed in parallel on both devices 5 
according to the manufacturers’ default recommendations. The MALDI-TOF MS results were 6 
compared with conventional biochemical identification tests and discordant results were 7 
resolved with 16S rRNA gene sequencing. The Bruker MS system gave high-confidence 8 
identification for 680 of 720 isolates (94.4%) whereas the Shimadzu MS showed a high-9 
confidence identification for 639 isolates (88.8%). These results showed also that only 6/680 10 
(0.9%) of the Bruker and 3/639 (0.5%) of the Shimadzu identifications gave an incorrect 11 
high-confidence identification at the species level. All the high-confidence MS identifications 12 
were accurate at the genus level. In addition, the Bruker MS system has identified 9 (69%) 13 
and the Shimadzu system 5 (38%) of 13 isolates that were not identified by conventional 14 
phenotyping methods. 15 
Interlaboratory species identification was assessed in a large international multicenter study 16 
(Mellmann, et al., 2009) using the Bruker system. In this study, eight participating 17 
laboratories received 60 blind-coded samples for MALDI-TOF MS species identification and 18 
98.75% were correctly identified at the species level. Six of the eight laboratories identified 19 
all 60 samples correctly. Out of a total of 480 samples, 6 samples were misidentified and one 20 
sample did not give any valid result due to low signal intensity. Thus, in contrast to other 21 
studies (Wang, et al., 1998), the utilization of a commercial system developed for routine use 22 
provided high reliability for bacterial identification.  23 
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Even though excellent results have been shown for bacterial identification by MALDI-TOF 1 
MS, both the diagnostic yield (identification at the genus, species or strain level) and the 2 
accuracy of identification depends on the taxonomy and in the quality of the databases. As 3 
shown by many studies, most of the bacterial groups including Enterobacteriaceae, 4 
nonfermentative Gram-negative bacteria, staphylococci and haemolytic streptococci were 5 
correctly identified as the species level (Seng, et al., 2009, Cherkaoui, et al., 2010, van Veen, 6 
et al., 2010).  Regarding staphylococci, the MALDI-TOF MS has brought up an important 7 
advantage by allowing rapid and simplified identification of both S. aureus and of some 8 
species belonging to coagulase-negative staphylococci (CoNS). Unlike most commercial 9 
identification systems that allow a rapid identification of only S. aureus, the MALDI-TOF MS 10 
allows a correct identification of various CoNS species (Speers, et al., 1998, Bernardo, et al., 11 
2002, Dupont, et al., 2010). In a comparative study between MALDI-TOF MS and two rapid 12 
identification automated systems, BD Phoenix (BD Diagnostic Systems, France) and Vitek-2 13 
(bioMérieux, France), the identification of 234 CoNS belonging to 20 different species 14 
showed that the MALDI-TOF performance was significantly better (93.2%) than Phoenix 15 
(75.6%) and Vitek-2 (75.2%) (Dupont, et al., 2010). Overall, MALDI-TOF appears to be 16 
excellent at identifying various staphylococci species as demonstrated by the congruence of 17 
99.3% (444/447) between MALDI-TOF and rpoB sequence-based identifications (Spanu, et 18 
al., 2011). Since CoNS can cause serious infections and are frequently associated with 19 
hospital-acquired infections, the rapid identification at the species level by MALDI-TOF is 20 
very useful in distinguishing clinically significant CoNS from contaminant strains (von Eiff, 21 
et al., 2002).   22 
Problematic identifications 23 
Most of the problematic identifications encountered in most of the recent studies concerned 24 
the viridans streptococci group, the pneumococci and anaerobic bacteria (Table 2). Viridans 25 
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17 
streptococci and pneumococci were commonly misidentified mainly due to an incomplete 1 
database reference library. In the study by Seng et al., nearly 50% of S. pneumoniae isolates 2 
were misidentified as Streptococcus parasanguinis (a close related species within the mitis 3 
group of Streptococcus species (Kawamura, et al., 1995)) because the database contained only 4 
three S. pneumoniae and two S. parasanguinis reference spectra (Seng, et al., 2009). The 5 
problem was solved by adding additional S. pneumoniae isolates reference spectra to the 6 
database which clearly indicates that the database need to be updated with multiple spectra of 7 
well-characterized streptococcal species. Until now, the identification of Streptococcus spp. 8 
remains a problem for MALDI-TOF MS identification especially for closely related species 9 
such as S. pneumoniae, S. mitis and S. parasanguinis. In the case of pneumococci, the use of 10 
MALDI-TOF MS for identification is further impaired by the weak extraction yield caused by 11 
the presence of a capsule. Thus, identification of S. pneumoniae should not solely rely on 12 
MALDI-TOF since false identification can results in important clinical outcomes. In the study 13 
of Cherkaoui et al., the diagnostic yield for streptococcal species and for Gram-negative 14 
anaerobes was less than 50% with an accuracy of high-confidence species identification of 15 
only 57.1% for streptococci with the Bruker system and of 71.4% with the Shimadzu MS 16 
system (Cherkaoui, et al., 2010).  17 
To date, only a few studies have analysed the usefulness of MALDI-TOF for routine 18 
identification of anaerobic bacteria. Seng et al. showed that an improved database is required 19 
since 50% of the total isolates (46) showing no identification by MALDI-TOF MS were 20 
anaerobic bacteria including Fusobacterium nucleatum and non-Clostridium anaerobes that 21 
had no reference in the Bruker database (Seng, et al., 2009).  In contrary, for anaerobic 22 
species (e.g several Bacteroides species) with sufficient spectra in the database, the 23 
identification by MALDI-TOF MS was better compared to conventional biochemical 24 
methods. These fastidious organisms are poorly identified using phenotypic methods with a 25 
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18 
lack of specificity and ambiguous or false identification. There is thus an important need to 1 
improve the database entries with additional anaerobes isolates (Bessede, et al., 2011). 2 
Similar to other studies, Blondiaux et al. have demonstrated the difficulties to identify 3 
viridans streptococci, pneumococci as well as HACCEK bacteria but also Shigella and several 4 
strictly aerobic bacteria (Aeromonas spp., Achromobacter spp., Alcaligenes spp.) (Blondiaux, 5 
et al., 2010). In this study, the mass spectra of six Shigella isolates were similar to several E. 6 
coli strains present in the Biotyper database. In another study, the misidentification of all 7 
Shigella sonnei isolates with E. coli was also documented (Seng, et al., 2009). 8 
Using 43 selected Mycobacteria strains, a mycobacterial database could be engineered 9 
comprising species-specific spectral profiles allowing identification of 44 species at the 10 
species level and of 9 strains of the M. abscessus complex and the M. tuberculosis complex at 11 
the mycobacterial clade level (Lotz, et al., 2010). Under the preanalytical and analytical 12 
conditions used in this study, subspecies of the M. abscessus complex (M. abscessus, M. 13 
massiliense and M. bolletti) and the M. tuberculosis complex (M. tuberculosis, M. bovis, M. 14 
microti and M. africanum) produced indistinguishable mass profiles due to their high degree 15 
of genetic similarity. Using this microbial database, 311 strains grown on solid medium were 16 
analysed by MALDI-TOF MS allowing a 97% correct identification, 67% at the species level 17 
and 30% at the complex level respectively. No misidentification was observed. When bacteria 18 
were grown on liquid media, correct identification was reduced to 77%, likely due to a 19 
reduced number of bacterial load or to potential interference with components of the liquid 20 
media. Interestingly, the authors observed than an increase in number of replicates (up to 5) 21 
did correlate with an increase probability of good identification, especially for slow-growing 22 
mycobacteria. Overall, several studies demonstrate that MALDI-TOF MS provides high 23 
reproducibility and specificity for mycobacterial identification and represents an alternative to 24 
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19 
other time consuming and fastidious conventional mycobacterial identification methods 1 
(Hettick, et al., 2004, Lefmann, et al., 2004, Pignone, et al., 2006, Lotz, et al., 2010).    2 
In our study analysing the performance of MALDI-TOF MS for the identification of 1371 3 
bacterial isolates routinely isolated in clinical microbiology laboratories and characterized by 4 
conventional methods, 1278 (93.2%) bacterial isolates were identified at the species level, 73 5 
(5.3%) were only identified at the genus level and 20 (1.5%) gave no reliable identification 6 
(Bizzini, et al., 2010). Among the 1278 isolates identified at the species level, 63 (4.9%) were 7 
misidentified. The majority of discordant results (42/63) were explained by discordances due 8 
to the MALDI-TOF database, 14 were due to poor discrimination of the spectra of closely 9 
related species such as Shigella spp. and E.coli, and 7 were caused by errors in the initial 10 
conventional phenotypic and biochemical identifications. 11 
Many of the bacterial identification that can be done only at the genus level are due to 12 
incomplete reference spectra covering many different isolates or species from a given genus. 13 
For instance, only 1 reference spectrum of P. acnes (strain DSM 1897) or Bacillus cereus are 14 
included in the Bruker database which is totally insufficient to cover the true diversity of these 15 
bacteria and thus to identify accurately these microorganisms (Bizzini, et al., 2010) . In 16 
addition, mislabelling of bacterial species in the database can cause misidentification by 17 
MALDI-TOF MS. In the study by Seng et al., 7 S. maltophilia isolates were incorrectly 18 
identified as P. hibiscicola which is an invalid name for a nonfermenting Gram-negative rod 19 
that was demonstrated to be S. maltophilia (Seng, et al., 2009).  20 
These studies show that a complete and representative database is an essential requirement for 21 
accurate identification of isolates by MALDI-TOF MS. A frequent update of the reference 22 
library database with spectra of appropriate poorly represented reference strains by the 23 
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manufacturers but also by routine diagnostic laboratories can significantly impact the 1 
MALDI-TOF identification performance. 2 
Impact of Sample preparation on MS identification 3 
Sample preparation has not been shown to be a major issue for problematic identifications. 4 
Samples and matrix prepared according to manufacturer’s instructions usually guarantee high 5 
quality spectral fingerprints required for efficient MALDI-TOF identifications. In most cases, 6 
the composition of an appropriate matrix containing strong solvent ensures efficient bacterial 7 
lysis required for MALDI-TOF analysis. When invalid results are initially obtained by 8 
MALDI-TOF MS following analysis of intact bacteria directly deposited on MALDI target 9 
plate, a step of bacterial protein extraction with acid-containing sample solvents improving 10 
cell lysis solve the problem in most cases. Bizzini et al. have shown that a formic acid-11 
acetonitrile extraction step was required to get a valid MALDI-TOF MS identification for 12 
25.6 % of the 1278 valid isolates (Bizzini, et al., 2010). The yield of valid score from direct 13 
application was almost the same, about 75%, for both Gram-positive and Gram-negative 14 
bacteria. For instance, the yields of valid scores without extraction step were equal to 79% for 15 
S. aureus, 82% for Enterococcus faecalis, 92% for Pseudomonas aeruginosa, 74% for E. coli, 16 
58% for Klebsiella pneumoniae and 58% for Staphylococcus epidermidis. However, the 17 
authors concluded that protein extraction prior to MALDI-TOF analysis should be performed 18 
only in particular cases known to be problematic such as colonies isolated from urine culture 19 
devices and/or MacConkey agar which contains crystal violet, a possible interfering substance 20 
affecting mass peak signals. Indeed, the higher identification rate obtained after an extraction 21 
step largely compensates the longer hand-on-time associated with an extraction procedure. 22 
This was also demonstrated by a study performed by Liu et al. that have developed a 23 
universal sample preparation for characterization of bacteria by MALDI-TOF MS (Liu, et al., 24 
2007). The protocol, consisting of a pretreatment of bacteria with acidic sample solvents and 25 
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21 
mixing with CHCA or CMBT matrix, could be used to analyse both Gram-positive bacteria, 1 
including spore-producing B. anthracis and non-spore-producing S. aureus, and Gram-2 
negative bacteria such as Y. pestis, E. coli, and B. cepacia that are characterized by high 3 
extracellular-polysaccharide contents.  4 
However, for some microorganisms, insufficient cell lysis and/or low quantity of sample 5 
material can be problematic for efficient MALDI-TOF identification and require the use of 6 
alternative identification approaches such as 16S rRNA gene sequencing.  A study by Bizzini 7 
et al. focusing on the identification of 410 clinical isolates that could not be identified with 8 
conventional laboratory methods showed that 133/410 (32.4%) isolates could not be either 9 
reliably identified with MALDI-TOF (Bizzini, et al., 2011). The failure to obtain a reliable 10 
identification was due to the absence of reference spectra in the BioTyper database for 58% 11 
(78/133) of the isolates and to poor protein spectral signals for 41.4% (55/133) of the isolates. 12 
The authors supposed that the poor spectrum quality observed could be due to either the 13 
difficulty to lyse the cell wall of some bacteria such as Gram-positive bacilli and/or to 14 
fastidious growth of some isolate, which yielded only small amount of available sample 15 
material. Difficult to identify microorganisms belonging to the genus Actinomyces, Gemella, 16 
Nocardia and Streptomyces could be observed in this study.   17 
The rate of successful identification is directly linked to the amount of microorganism 18 
available. We have observed that the rate of correct identification is especially poor when the 19 
subculture has been incubated on a plate for less than 4 hours (Figure 3). Thus, when we tried 20 
to identify various bacterial species isolated from positive blood cultures and sub-cultured on 21 
agar, we observed that only 30% of bacteria could be successfully identified after 2 hours of 22 
incubation (Figure 3C). This identification rate was significantly lower for Gram-positive 23 
cocci, remaining below 60% after 6 hours. This is likely due to the amount of bacteria 24 
available after short incubation period (Figure 3B). Indeed, using ten-fold dilutions of E. coli 25 
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22 
strain ATCC 25922 and S. aureus strain ATCC 25923, we could show that as much as 106 1 
bacteria/well were necessary to consistently obtain a spectrum (Figure 3A) ensuring a score 2 
above 2 and that when the amount of bacteria was ranging between 102 to 104 bacteria/well, 3 
the score was always below 1.7 (data not shown). Lower amount of bacteria may however be 4 
identified with a different identification algorithm. Hsieh et al. have demonstrated that as few 5 
as 5 x 103 cells from a pure strain can be identified by MALDI-TOF MS using particular 6 
analysis approaches based on selected markers (Hierarchical Clustering Analysis and direct 7 
classification model construction) (Hsieh, et al., 2008). Interestingly, using the classification 8 
model analysis, the authors showed that successful MALDI-TOF MS identification can also 9 
be achieved from a bacterial species mixture consisted of as less as 3 x 104 cells. This study 10 
opens new perspectives for the direct identification of low abundant bacteria located in mixed 11 
flora without the pre-requirement of bacterial isolation and culturing.  12 
Fungal identification 13 
Fungal identification still largely relies on phenotypic traits. However, a few days are 14 
necessary to obtain mature fungi with phyalids (phyalids are conidiogenous cells observed in 15 
a type of fungal asexual reproduction leading to the production of conidia). This time delay 16 
may be important given the morbidity and mortality of fungal infections, especially common 17 
and life threatening among neutropenic patients. Thus, like PCR and sequencing, MALDI-18 
TOF has the potential to provide accurate and objective identification at species level, with 19 
the additional advantage of rapidity and reduced costs compared to PCR and sequencing. 20 
MALDI-TOF MS systems for the identification of microorganisms was successfully adapted 21 
for the identification of fungi in the past 10 years. In 2000, Welham et al. were among the 22 
first to perform fungal identification using the MALDI-TOF MS approach (Welham, et al., 23 
2000). Three fungal species, Penicillium spp., Scytalidium dimidiatum and Trychophyton 24 
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23 
rubrum, showed distinct spectral fingerprints allowing accurate species distinction. Since 1 
then, many studies have demonstrated the usefulness of the MALDI-TOF application for the 2 
identification of various fungal groups such as penicillia, aspergilla, Fusarium, Trichoderma 3 
and dermatophytes. However, until now, MALDI-TOF MS is mainly used for the routine 4 
identification of yeasts whereas further development has to be accomplished in database 5 
libraries and sample preparation protocols in order to implement this identification approach 6 
to other group of fungi such as filamentous fungi and dermatophytes. 7 
Yeasts 8 
The databases of the associated softwares (Biotyper and SARAMIS) of the two main 9 
MALDI-TOF instruments contains reference spectra of multiple clinical yeast isolates, 10 
including several Candida spp. and Cryptococcus neoformans, which allows the use of 11 
MALDI-TOF in routine yeast laboratory identification (Table 1).  12 
Marklein et al. evaluated MALDI-TOF MS for the rapid routine identification of clinical 13 
yeast isolates and showed that 92.5 % (247/267) of clinical isolates of Candida, 14 
Cryptococcus, Saccharomyces, Trichosporon, Geotrichum, Pichia, and Blastoschizomyces 15 
spp. were accurately identified (Marklein, et al., 2009). In a study performed by Van Veen et 16 
al., 85% of 61 yeast isolates comprising 12 different species were correctly identified without 17 
occurrence of major errors (van Veen, et al., 2010). Bizzini et al. achieved a 100% correct 18 
identification of 24 yeast isolates belonging to 12 different species (Bizzini, et al., 2010). The 19 
suitability of the two commercially available MALDI-TOF MS systems, Bruker and 20 
Shimadzu, and their respective associated softwares and databases, Biotyper and Saramis, was 21 
tested for rapid species identification of yeasts in a clinical diagnostic approach (Bader, et al., 22 
2010). Both MALDI-TOF MS systems have showed a similar species identification rate of 23 
97.6 % for Bruker/Biotyper and 96.1 % for Shimadzu/Saramis that were comparable to the 24 
biochemical tests rate (96.9%). Based on isolates that were contained in the respective 25 
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24 
database, no misclassifications were seen with Saramis and fewer misidentifications were 1 
reported by the Biotyper compared to classical approaches. Using the Bruker MALDI-TOF 2 
system, Stevenson et al. have created a spectral database library for 109 reference strains of 3 
yeast representing 44 species and 8 genera to evaluate the use of MALDI-TOF MS for the 4 
rapid identification of yeast species (Stevenson, et al., 2010). This library was challenged with 5 
197 clinical isolates. Three isolates gave no spectral score since no reference spectrum were 6 
included in the database library. Of the remaining 194 clinical isolates, 192 (99.0%) were 7 
correctly identified at the species level and two organisms gave consistently low spectral 8 
scores that could not be identified. In summary, the use of MALDI-TOF mass spectrometry 9 
for the identification of clinically relevant yeasts is rapid and accurate providing that the 10 
database is constructed with a comprehensive collection of accurately identified reference 11 
strains. 12 
Filamentous fungi 13 
Chen et al. successfully identified several Penicillium species directly from intact fungal 14 
spores mixed with the MALDI matrix (Chen & Chen, 2005). Hettick et al. have achieved 15 
100% correct identifications of 12 Penicillium species by bead beating fungal samples 16 
resuspended in a acetonitrile/trifluoroacetic acid solvent prior to MALDI-TOF analysis 17 
(Hettick, et al., 2008). The observed mass spectra contained abundant peaks in the range 18 
5000-20000 m/z allowing unambiguous discrimination between species. In addition, a 19 
biomarker common to all Penicillium mass fingerprints was observed at m/z of 13.9 kDa.  20 
Using an extraction method similar to that used for Penicillium species, Hettick et al. obtained 21 
also highly reproducible mass spectral fingerprints for 12 species of Aspergillus and 5 strains 22 
of A. flavus (Hettick, et al., 2008). The 12 species were correctly identified but only a 95% 23 
accurate identification was obtained at the strain level. It was also pointed out that Aspergillus 24 
niger could not be distinguished from Aspergillus chevalieri. The authors concluded that the 25 
Page 24 of 73
ScholarOne Support 1-434/964-4100
FEMS Microbiology Reviews
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
25 
identification of Aspergillus spp. with MALDI-TOF MS would require a comprehensive 1 
database of at least 180 species of Aspergillus. A study showed that different species of 2 
Aspergillus, including aflatoxigenic and non-aflatoxigenic spp., could be characterized 3 
directly from intact spores (Li, et al., 2000). However, the authors reported certain 4 
discrepancies due to the difficulties encountered to discriminate the spectra obtained with 5 
some of the analysed species. A database including the reference spectra of 28 clinically 6 
relevant Aspergillus species was engineered in a recent study by including species-specific 7 
fingerprints of both young and mature colonies of reference strains (Alanio, et al., 2010). The 8 
performance of the database was tested on 124 clinical and 16 environmental Aspergillus 9 
isolates resulting in a 98.6% (138/140) correct identification with 100% specificity (0% 10 
misidentification). This study has demonstrated that a complete fingerprint database including 11 
spectra from both young and mature fungal colonies makes MALDI-TOF a robust method for 12 
Aspergillus species identification regardless of the maturity of the tested isolates. 13 
The identification of multiple Fusarium spp. has also been demonstrated by various studies. 14 
In the study by Marinach-Patrice et al., 62 strains or isolates belonging to 9 Fusarium spp. 15 
were subjected to both molecular identification and MALDI-TOF MS analysis (Marinach-16 
Patrice, et al., 2009). Following updating of the BioTyper database with 13 strains of 5 17 
Fusarium spp., 57 (92%) strains were correctly identified by MALDI-TOF MS analysis. Only 18 
one Fusarium pseudonygamai isolate was misidentified and four Fusarium isolates were not 19 
identified due to absence of reference spectra in the database. MALDI-TOF MS was also used 20 
successfully to identify 5 mycotoxin-producing Fusarium spp. by direct analysis of spores 21 
which yielded highly reproducible MS profiles (Kemptner, et al., 2009).  22 
Dermatophytes 23 
The most important clinical fungal dermatophytes species, T. rubrum, Trychophyton 24 
interdigitale, Trychophyton tonsurans and Arthroderma benhamiae, originating from skin and 25 
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nail were recently identified using the SARAMIS database (Erhard, et al., 2008). Except for 1 
one T. rubrum strain, a high level of confidence (99.9%) was obtained in this study where 2 
sufficient MS spectra were used to produce a super-spectrum for each species.    3 
Problematic identifications 4 
Similar to bacteria, absence of identification or misidentification of fungal species by 5 
MALDI-TOF MS analysis are essentially due to absence, mistakes or incomplete reference 6 
spectra in the database (Table 2). High quality MS spectra are usually easily obtained with 7 
both fungal hyphae and spores following manufacturer’s instruction or based on the 8 
recommendation of reference studies. For instance, because of their cell wall structure, yeasts 9 
need an extraction step to yield a valid score of identification by MALDI-TOF MS. In the 10 
study of Bizzini et al., only 4% (1/24) of the valid results were obtained by direct application 11 
of the colony on the MALDI plate (Bizzini, et al., 2010) and an extraction method prior to 12 
analysis by MALDI-TOF was also shown to be mandatory to obtain appropriate spectra in the 13 
study performed by van Veen et al. (van Veen, et al., 2010). The spectra of several 14 
Penicillium spp. obtained from bead beating fungal samples resuspended in an acidic solvent 15 
prior to MALDI-TOF analysis was more discriminative (abundant peaks in the range 5000-16 
20000 m/z) than spectra obtained directly from intact spores (range of 2600-7378 m/z) (Chen 17 
& Chen, 2005, Hettick, et al., 2008). However, Valentine et al. identified Aspergillus niger, 18 
Rhizopus oryae, Trichoderma reesei and Phanerochaete chrysosporium using either intact 19 
spores, hyphae or extracts showing that intact cells, sonicated cells and acid-treated cells 20 
yielded similar spectra (Valentine, et al., 2002).  21 
The main problem is that, unfortunately, very few reference spectra are currently included in 22 
the database of commercially available MALDI-TOF MS systems. Most of the studies 23 
showing that the MALDI-TOF MS identification is a powerful system for the characterization 24 
and identification of fungi have built and used their own reference spectra database and have 25 
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developed their own sample preparation techniques. There is thus still a lack of standardized 1 
extraction protocols regarding filamentous fungi. 2 
In addition, the spectral signal of filamentous fungi may be strongly influenced by the 3 
phenotype of the fungus including basidiospore, monokaryon, dikaryon, fruiting body, surface 4 
mycelium, strands and substrate mycelium. Moreover, vegetative mycelium grown on agar 5 
shows multiple zones that correspond to different ages or developmental stages. These 6 
variations may thus influence the spectral reproducibility of the same isolate and a 7 
comprehensive database of filamentous fungi should include MS fingerprints of several 8 
different developmental forms to guarantee high yields and accuracy of identification as 9 
demonstrated by Alanio et al. (Alanio, et al., 2010).  10 
Direct identification from samples 11 
Given the accuracy of MALDI-TOF for bacterial identification, this technology might be 12 
directly applied to some clinical samples, such as blood, urines, cerebrospinal fluid, pleural 13 
fluid, peritoneal liquid and synovial fluid. The major limitation is the amount of bacteria 14 
present in the samples and the limit of detection of current MALDI-TOF protocols. To 15 
circumvent this difficulty, large volumes are used for blood and urines and an additional 16 
enrichment by culture is available for blood (see paragraphs below). Regarding cerebrospinal 17 
fluid, Nyvang Hartmeyer et al. successfully identified S. pneumoniae 30 minutes after 18 
receiving a sample supporting the proof-of-concept (Nyvang Hartmeyer, et al., 2010). 19 
However, practically, bacterial identification from cerebrospinal fluid, strongly limited by the 20 
low bacterial load and the limited volume available, is yet not applicable in routine diagnostic 21 
laboratories.  22 
Blood (hemoculture) 23 
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Bloodstream infection, septic shock and endocarditis represent severe diseases with important 1 
mortality and morbidity. Blood culture represents the best way to establish the etiology of 2 
such infections and to guide antimicrobial treatment. This is important since rapid and 3 
appropriate antimicrobial therapy is pivotal to reduce poor outcome (Kollef, 2000). Indeed, 4 
the fatality rate was 20% for bloodstream infection patients treated with appropriate therapy, 5 
and 34% for patients treated with inappropriate therapy (Leibovici, et al., 1998). The rapid 6 
notification of the Gram stain result from positive blood culture has also a positive impact for 7 
adaptation of antimicrobial regimen (Munson, et al., 2003). Consequently, the precise 8 
identification of a microorganism isolated from positive blood culture early after Gram stain 9 
notification will likely help clinician to better adapt the antimicrobial therapy. As an example, 10 
the impact on the choice of the antibiotic will likely be significant when Gram-positive cocci 11 
are identified from blood cultures, since the antibiotic susceptibility of E. faecium is clearly 12 
different from that of alpha-hemolytic streptococci.  13 
Quantitative blood-cultures have demonstrated that bacterial load during bloodstream 14 
infection is very low in adults, often less than 1-10 colony forming unit/ml. In practice, blood 15 
samples are inoculated into bottles containing broth media and incubated in automated 16 
instruments monitoring CO2 concentrations released during bacterial growth. At the 17 
automated growth detection time, the bacterial load may reach a heavy growth up to 106 to 18 
108 colony forming units/ml. In our laboratory, Enterobacteriaceae, Pseudomonas aeruginosa 19 
and aerobic Gram-positive cocci were generally detected when present at 107 bacteria/ml. 20 
Such bacterial concentration might be adequate to allow accurate bacterial identification using 21 
mass spectrometry. 22 
However, the blood culture bottle fluid represent a complex solution with multiple non-23 
bacterial proteins isolated from patient’s blood and nutrient growth media. These proteins 24 
alter the specific bacterial mass spectrometry profile obtained by MALDI-TOF and have a 25 
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detrimental effect on the performance of algorithm used to query the database containing 1 
bacterial mass spectrometry profiles. 2 
The preparation of a bacterial pellet from positive blood culture includes a differential 3 
centrifugation step to discard blood cells, an erythrocyte lysis step and a subsequent washing 4 
step to remove additional non-bacterial components. Application of this protocol allows the 5 
identification in less than 1 hour as compared to overnight growth of bacteria required to 6 
obtain pure colonies for biochemical identification. 7 
Recent studies (Table 3) have shown that a correct identification by MALDI-TOF is obtained 8 
in >80% of cases starting from blood culture bottles. The results varied according to the 9 
bacterial pellet preparation protocol and the type of microorganism present in blood cultures. 10 
Using ammonium chloride as lysing agent, 89% of Gram-negative bacteria and 73% of Gram-11 
positive bacteria (i.e. 90% for Staphylococci and 33% for Streptococci) were correctly 12 
identified at the species level (Prod'hom, et al., 2010). No identification was observed in 21% 13 
of cases.  The lower performance of MALDI-TOF for Gram-positive bacteria and particularly 14 
Streptococci has also been observed in other studies (Table 3). Similar to MALDI-TOF 15 
identifications from pure microbial isolates, several hypothesis have been suggested to 16 
explain discordant results obtained from blood cultures: i) the close relatedness of the 17 
different species especially within Streptococci, notably within Streptococcus mitis group 18 
(i.e., S. pneumoniae, S. mitis, S. sanguinis, S. oralis) conferring closely related MALDI-TOF 19 
spectrum profiles, ii) the cell wall composition of Gram-positive bacteria conferring 20 
resistance to lysis. In addition, the presence of capsules in different species (S. pneumoniae, 21 
Haemophilus influenzae, Klebsiella pneumoniae) may also explain the lower performance of 22 
MALDI-TOF. 23 
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The performance of MALDI-TOF for the identification of fungi in blood culture is low. In 1 
one study (Ferreira, et al., 2010), no fungi (0/18) were identified at the species level and only 2 
one at the genus level. This poor performance is attributed to the relatively low load of fungi 3 
observed in positive blood culture and to the presence of residual blood protein which co-4 
migrates during the MALDI-TOF assay, which impairs the performance of the diagnostic 5 
algorithm. To circumvent this detrimental effect, a reference database of fungi obtained from 6 
blood culture spiked with fungi was established to obtain correct identification at the species 7 
level (Marinach-Patrice, et al., 2010). 8 
Limitation of the MALDI-TOF identification was also observed for mixed bloodstream 9 
infection, where only one bacterium could be identified (La Scola & Raoult, 2009, 10 
Moussaoui, et al., 2010, Szabados, et al., 2011). 11 
The impact of the broth on the spectral quality and thus on the rate of identification has been 12 
analysed in several studies. The first published studies have used bottles adapted to the 13 
BACTEC system (Becton Dickinson, Franklin Lakes, NJ, USA). More recently, bottles with 14 
and without charcoal adapted to Bact/ALERT automated instruments have been tested 15 
(bioMérieux, Marcy l’Etoile, France). In this system, charcoal is used to inactivate 16 
antimicrobial agents present in patient's blood. In one study, the rate of identification using 17 
MALDI-TOF was 30% without charcoal and decrease to only 8% when charcoal was present 18 
(Szabados, et al., 2011). Another study compared the performance of identification using 19 
MALDI-TOF with positive blood culture obtained from three automated systems:  BACTEC, 20 
VERSATREK (Trek diagnostic Systems, Cleveland, USA) and BactT/ALERT. The rate of 21 
direct identification of bacteria cultured in these 3 automated blood culture devices were 76%, 22 
69% and 62% for the investigated samples, respectively (Romero-Gomez & Mingorance, 23 
2011). 24 
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The importance of the protein extraction method was compared with the so-called intact cell 1 
method, which consist in the direct deposition on MALDI plate of bacterial pellet obtained 2 
from positive blood culture. In one study, the performance of MALDI-TOF identification at 3 
the species level was 47% for the intact cell method compared to 76% for the protein 4 
extraction method (Ferreira, et al., 2010). The simple extraction method used in this study 5 
improves significantly the performance of MALDI-TOF identification rate. In our laboratory, 6 
we now use this approach on a routine basis, with a turnaround time estimated to about 1 7 
hour. However, to be efficient and have such a low turnaround time, there is a need to 8 
prioritize identification of bacteria isolated from blood cultures over other routine applications 9 
of the MALDI-TOF. Thus, this activity somehow delays other microbial identifications, as 10 
shown in Figure 4. 11 
In conclusion, the application of MALDI-TOF identification to microorganism pellets 12 
obtained from positive blood culture allows a rapid identification of microorganisms growing 13 
in blood culture which is important for the management of bloodstream infections.  14 
Urine 15 
Since the bacterial amount in urine taken from patients with urinary tract infection is often > 16 
105 bacteria/ml, the use of MALDI-TOF directly on urine has been investigated by numerous 17 
groups. However, since only about 1 to 2µl of liquid may be deposited on the MALDI-TOF 18 
microplate, results were not accurate when untreated urine are directly deposited and thus 19 
various pre-treatment steps have been tested with different outcomes. Using two consecutive 20 
centrifugation steps (low speed to remove leucocytes and high speed to collect the bacteria), 21 
Ferreira et al. could accurately identify as much as 94.2% of bacteria (Ferreira, et al., 2010). 22 
However, they only included in their study urine with > 105 bacteria/ml. When investigating a 23 
simplified protocol in our laboratory for the identification of E. coli (single centrifugation 24 
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step), the results was acceptable when the bacterial concentration was of 107 and 108 1 
bacteria/ml with 69% and 70% of samples being accurately identified at the species level 2 
(score > 2). However, the yield was poor with lower bacterial load (Figure 5). Given the huge 3 
amount of urine processed on a daily basis, the low value of early identification and the 4 
requirement of bacterial isolation in pure culture for antibiotic susceptibility testing, it appears 5 
that the MALDI-TOF on urine is not cost-effective and not efficient enough to be 6 
implemented directly on urine samples. Indeed, since most urinary isolates are E. coli (> 80% 7 
among uncomplicated cystitis occurring in young women and about 50% in complicated 8 
urinary tract infections), the use of a chromogenic agar (i.e. Urid, bioMérieux) coupled with 9 
simple phenotypic tests such as indole represents a simpler way to identify most strains. 10 
MALDI-TOF will then be mainly used to identify the remaining species starting from 11 
colonies.  12 
Maintenance and quality controls 13 
The MALDI-TOF MS is increasingly used in clinical diagnostic laboratory for microbial 14 
identification with reliable results for bacterial identification at species level. 15 
MALDI-TOF results may however be impaired by problems arising during extraction, for 16 
instances (i) when testing encapsulated bacteria (Streptococcus pneumoniae, Klebsiella 17 
pneumoniae), (ii) when testing bacteria such as Streptomyces, that exhibit a particular cell 18 
wall that reduces the yield of protein extraction, (iii) when the extraction protocol is not 19 
properly conducted, or (iv) when the reagents used for extraction are outdated or impaired by 20 
inadequate storage. Problems (i) and (ii), due to intrinsic bacterial properties, may only be 21 
circumvented by the development of specific extraction protocols and problems (iii) and (iv) 22 
might be prevented by an adequate quality program. The performance of the extraction step 23 
and of the MALDI-TOF mass spectrometer may be checked by routinely testing a few 24 
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selected bacterial strains, for which spectra are available in the database. This control should 1 
ideally be done in parallel with and without a specific extraction step. We thus implemented 2 
in our laboratory routine internal quality controls that test the quality of the extraction step on 3 
two different bacterial species (E. coli ATCC 25922 and S. aureus ATCC 25923). To set-up 4 
this quality control, we first investigated the reproducibility of the extraction step (see Figure 5 
2 & paragraph on reproducibility). This allowed us to define conserved peaks [peaks present 6 
in 10/10 replicates]. Then, we routinely tested once a week both bacterial species. Since score 7 
values were always above 2 and to obtain a better expression of the quality of the extraction, 8 
we decided to report the proportion of conserved peaks detected, considering a peak as 9 
present only when its intensity was above 200. Indeed, the rate of detection of conserved 10 
peaks reflects not only the quality of the sample but also the protein yield and the spectral 11 
quality (Figure 6). 12 
MALDI-TOF results may also be impaired by inadequate deposit of the sample on the 13 
microplate and by poor cleaning of the microplate between runs. Inadequate deposit of 14 
samples is relatively rare when starting from bacterial colonies and the learning curve is rapid 15 
with most laboratory technicians being already experts in depositing appropriate amount of 16 
bacteria after only a few training days. However, erroneous identification may occur due to 17 
well inversions, especially when large series are processed and when stress is increased by 18 
human resources shortage. 19 
Poor cleaning of the microplate is a problem only encountered by Bruker users since 20 
Shimadzu users will use disposable MALDI-TOF plates. Bruker commonly propose to use 21 
trichlorofluoroacteate (TFA) or guanidium to clean microplates between usages. Since TFA is 22 
associated with significant occupational hazard (eye, skin and respiratory toxicity), we used in 23 
our laboratory an alternative protocol in order to clean MALDI-TOF microplate. This 24 
protocol, initially proposed by Bruker, which mainly uses ethanol and mechanical cleaning of 25 
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target plates, is however insufficient to properly clean MALDI-TOF microplates. Indeed, 1 
when investigating cleaned plates by testing them only in presence of matrix, we could obtain 2 
some accurate identification with score > 2 and corresponding to the same bacterial species 3 
investigated the day before. Such accurate identifications obtained after plate cleaning could 4 
rarely correspond to wells where some material was still present (Figure7A, wells C4, E3 and 5 
E4), but also occurred in apparently clean wells. Thus, a systematic control of the microplates 6 
should be done and the cleaning protocol adapted when necessary. Noteworthy, disposable 7 
microplates are now also available for Bruker users. 8 
MALDI-TOF results may also be impaired by technical problems and/or poor maintenance of 9 
the MALDI-TOF device. To identify possible technical problems and to recalibrate the mass 10 
spectrometry apparatus, we routinely use in Lausanne the calibration control proposed by 11 
Bruker. This control (coined BTS) consists of lyophilised E. coli extracts and 2 supplementary 12 
proteins, RNAse A and myoglobin, which respectively exhibit peaks at 13683 and 16952 m/z 13 
(Figure 7B). Finally, in the future, external quality control should be implemented. 14 
Appropriate maintenance (Figure S1) is also essential to warrant accurate bacterial 15 
identification. Vacuum failure, and thus MALDI-TOF MS functional disturbance (see figure 16 
1), might be observed due to the presence of dust on plastic joints or to the ageing of these 17 
plastic joints (Figure S1 C and D). Dust exposure of the MALDI-TOF apparatus might be 18 
reduced by placing the mass spectrometer in a quiet area, without draft. Carbonisation of 19 
bacteria embedded in the matrix material following each laser pulse is also a source of 20 
concern, since the laser source may be soiled (Figure S1 D). With the Bruker instrument, the 21 
rate of dirtiness present on the laser source may be indirectly estimated according to the 22 
number of shots needed to obtain a correct identification. Maintenance should ideally be done 23 
before the dirtiness rate reach 80%, i.e about 4 times a year if 3 to 5 microplates are tested per 24 
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day. Of course, frequency of maintenance of the MALDI-TOF should be increased if the 1 
apparatus is heavily used or located in a crowded/dusty area. 2 
Despite adequate maintenance and correct procedures, some microbial groups will repeatedly 3 
be misidentified due to poor content of some databases. Thus, it appears critical not only to 4 
implement a quality control program targeting routine procedure but also to incrementally 5 
improve the quality of the database.  In conclusion, quality controls might help to improve the 6 
quality of proteins extraction, MALDI-TOF analysis and completeness of databases. This will 7 
thus further improve the accuracy and usefulness of MALDI-TOF. 8 
Accuracy, Time and Cost effectiveness 9 
The MALDI-TOF MS approach represents a new tool that has the potential to replace 10 
conventional identification techniques for a majority of routine isolates encountered in clinical 11 
microbiology laboratories. The performance of the MALDI-TOF MS approach has been 12 
compared in several studies (Seng, et al., 2009, Bizzini, et al., 2010, Cherkaoui, et al., 2010, 13 
van Veen, et al., 2010) with multiple routine phenotypic identification methods, such as semi-14 
automated Gram staining (Aerospray Wescor® ; Elitech), catalase and oxidase determination 15 
tests, automated identification by Vitek ® (bioMérieux), the Api Anaérobie BioMérieux® 16 
identification strip for anaerobes (bioMérieux), the Slidex Staph plus system (bioMérieux). 17 
These studies showed that the MALDI-TOF technique has a high accuracy for most microbial 18 
identifications and performed equally as well as or better than conventional techniques. For 19 
instance, van Veen et al. showed that significantly more bacterial isolates could be identified 20 
to the species level by MALDI-TOF MS, with a special higher performance for staphylococci 21 
and bacteria from the HACCEK group (van Veen, et al., 2010). Similarly, Bader et al. have 22 
shown that identification of yeast species with MALDI-TOF MS systems gave an overall 23 
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species identification rate (97.9 % for Bruker and 96.1% for Shimadzu) that was comparable 1 
to the one obtained with the biochemical tests (96.9%) (Bader, et al., 2010). 2 
The most striking differences between MALDI-TOF technique and conventional 3 
identification methods are observed in the estimated time and costs required for sample 4 
identification. The cost of bacterial identification by MALDI-TOF MS was estimated to 5 
represent only 17-32% (around €1.43/sample) of the costs of conventional identification 6 
methods (around  €4.6-8.23/sample) in the study performed by Seng et al. (Seng, et al., 2009), 7 
which is supported by at least two other prospective studies (Bizzini, et al., 2010, Cherkaoui, 8 
et al., 2010). Cherkaoui et al. have shown that the reagents required for phenotypic 9 
identification using modern automated platforms costs at least around $10 per isolate whereas 10 
MS-required reagents do not exceed $0.50 (Cherkaoui, et al., 2010). The expensive prices of 11 
MS instruments are comparable to other common bacteriology laboratory equipment such as 12 
automated blood culture and 16S sequencing devices but the running costs are significantly 13 
cheaper than those of conventional identification methods. Thus, in our laboratory, we 14 
estimated that the reagents costs spared during a year are of approximately 40’000 euros 15 
(Table S2). Of course, this cost analysis did not include the cost of maintenance, neither for 16 
MALDI-TOF nor for automated phenotypic identification systems such as Vitek.  17 
Compared to conventional identification methods, MALDI-TOF has been shown to confer in 18 
most cases a significant gain of both technician working time (preanalytical procedure to 19 
prepare samples) and turnaround time (automated analytical procedure to obtain results). 20 
The time needed for bacterial identification from intact cells was 6-8.5 min versus 5-48h for 21 
conventional identification as estimated by Seng et al. (Seng, et al., 2009). When an 22 
extraction step is required, Bizzini et al. have estimated that the extraction procedure for a 23 
single sample takes approximately 6 min, a time per sample that is further reduced during 24 
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batch processing (Bizzini, et al., 2010). The time effectiveness gained with MALDI-TOF 1 
identification compared to classical identification approaches is even more accentuated when 2 
several isolates are analysed in parallel. As reported by Cherkaoui et al., the analysis of 10 3 
isolates in parallel can be accomplished in less than 15 min with limiting working time by MS 4 
whereas more than 360 min would be required on an automated system with more hands-on 5 
time for each isolate (Cherkaoui, et al., 2010) demonstrating that MALDI-TOF MS provide a 6 
reduction of both working and turnaround times. Regarding yeast identification by MALDI-7 
TOF MS, Marklein et al. showed that this technique required minimal time for technicians to 8 
process yeast samples for analysis and to interpret the results (Marklein, et al., 2009). The 9 
MALDI-TOF identification procedure from single yeast colonies on the agar plate was 10 
generally completed within 10 min per isolate and within 3h for 96 samples. In contrast, the 11 
identification of germ tube-negative Candida species by phenotypic methods can require 12 
incubation periods of up to 72h, a significant longer turnaround time compared to MALDI-13 
TOF. Molecular approaches have been or are currently under development to provide efficient 14 
identification of yeasts with a more rapid and reliable efficiency than classical phenotypic 15 
methods. However, high-resolution DNA-based molecular techniques such as 26S rRNA or 16 
internal transcriber spacer DNA sequencing and real-time PCR assays are expensive and 17 
time-consuming and appear in most cases less convenient than MALDI-TOF MS for routine 18 
laboratory identifications (Schabereiter-Gurtner, et al., 2007, Montero, et al., 2008, Seyfarth, 19 
et al., 2008). Nucleic acid-based identification strategies suffer problematic limitations in 20 
terms of (1) technical problems (inhibitory compounds, contamination, separate areas for 21 
sample preparation/amplification/analysis), (2) reagent and labour costs, (3) spectrum of 22 
species identification in a single assay often limited to a few individual species, and (4) much 23 
longer turnaround time than MS. Thus such lengthier, costlier and labour-intensive alternative 24 
to MALDI-TOF MS are usually reserved for the identification of the small minority of 25 
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isolates not identified by MS alone or by other conventional phenotypic and/or biochemical 1 
identification approaches. 2 
Taxonomy and microbial typing 3 
Taxonomic usefulness of MALDI-TOF MS 4 
Taxonomy is the systematic classification of organisms based on their phenotypic, genetic and 5 
phylogenetic characteristics. Thus, various phenotypic approaches (morphology, biochemical 6 
reactions, and sugar assimilation) have been used by microbiologists to classify 7 
microorganisms. However, genome analysis through sequencing of bacterial genes or of the 8 
entire genome currently represents the gold-standard of microbial taxonomy, although it 9 
should always be confronted to phenotypic traits in a polyphasic approach. MALDI-TOF MS 10 
represent an additional approach to classify microorganisms based on phenotypic traits. As 11 
previously shown in several studies mentioned in this review, MALDI-TOF MS systems give 12 
accurate and reproducible results at the species level that are in most cases concordant with 13 
genomic identification methods and consequently, MALDI-TOF has the potential to be used 14 
in polyphasic taxonomy. For instance, in contrast to housekeeping genes sequencing such as 15 
16SrRNA that provide taxonomical data on a single gene at a time, MALDI-TOF MS 16 
fingerprints provide information about multiple protein components that characterize a 17 
microorganism. In addition, MALDI-TOF fingerprints provide data of both the presence 18 
(conservation/divergence) and the intensity (expression level) that together compose a two 19 
dimensional taxonomical asset which offer a better discriminative resolution for 20 
microorganism classification.   21 
Microbial typing and identification at the subspecies level 22 
MALDI-TOF MS allows identification of microbes at the species level and sometimes at the 23 
subspecies level but several studies have shown that the requirements for MALDI-TOF MS-24 
dependent microbial typing are different and more complex than those required for routine 25 
Page 38 of 73
ScholarOne Support 1-434/964-4100
FEMS Microbiology Reviews
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
39 
microbial identification. This is a challenge for clinical laboratories that want to use MALDI-1 
TOF MS for routine strain typing. Relatively few biomarkers (5 to 10 peaks) are usually 2 
required for the identification of microbial isolates at the species level whereas a much larger 3 
number of reproducible peaks is needed for subspecies identification (Dieckmann, et al., 4 
2008). Many studies cited in this review using conventional MALDI-TOF procedure could 5 
not directly identify taxonomic entities like species or subspecies with an accuracy of 100% 6 
without the assistance of DNA-based methods. Microbial typing and thus microbial 7 
characterization at the subspecies level required very different sample preparation and 8 
analytical procedures (Murray, 2010). As mentioned previously in this review, accurate 9 
sample preparation is generally unnecessary for microorganism identification but for strain 10 
typing and subspecies identification, a rigorous optimization of testing parameters appears to 11 
be crucial. The challenge is to obtain a sufficient number of reproducible markers with 12 
specificities below species-level specificity (Rupf, et al., 2005, Vargha, et al., 2006, 13 
Dieckmann, et al., 2008). For instance, the sample preparation procedure (whole cell or 14 
protein extraction), the protein concentration, the type of matrix, the sample:matrix ratio, the 15 
concentration of acid added to the matrix and the growth medium are examples of technical 16 
parameters that can have a significant influence on the MALDI-TOF spectral profile of 17 
biomarkers (Vargha, et al., 2006, Dieckmann, et al., 2008).  18 
The choice of analysis solutions used to process mass spectra can have a significant impact on 19 
the power of discrimination and thus on the ability to distinguish closely related isolates. 20 
Maximizing reproducibility is also critical for accurate microbial characterization. One of the 21 
major limitations of MALDI-TOF-based microbial typing is primarily due to the algorithmic 22 
methods used to analyse the protein profiles. Several similarity coefficients can be used to 23 
determinate level of similarities. Some account only for peak presence/absence such as the 24 
Dice similarity coefficient, whereas others take also in consideration the peak intensities, such 25 
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as cosine and Pearson product-moment correlation coefficients. The chosen similarity 1 
coefficient affects the reproducibility and the discriminatory power of the method. Several 2 
studies have demonstrated that the Pearson coefficient appears to be more adequate for the 3 
correct classification of microbial isolates. A study by Giebel et al. showed that the Pearson 4 
product-moment correlation coefficient permitted a more accurate classification of 5 
Enterococcus spp. isolates than the Dice similarity coefficient (Giebel, et al., 2008). 6 
Similarly, the use of the Pearson correlation coefficient allowed a 28% increase in the rate of 7 
correct classification of E.coli isolates (Giebel, et al., 2010). Using optimal sample 8 
preparation and MALDI conditions for discrimination at the strain level and by using the 9 
Pearson coefficient, Vargha et al. have shown that MALDI-TOF MS offered a better 10 
discriminatory power than 16S rRNA gene sequencing for the classification at the subspecies 11 
level of Arhtrobacter isolates (Vargha, et al., 2006). For instance, members of the A. 12 
globiformis cluster have 99-100% sequence similarity whereas MALDI-TOF MS similarity is 13 
60-95%. 14 
In some cases, the identification of multiple or single unique subspecies biomarkers have been 15 
used to discriminate closely related microbial isolates exhibiting highly similar mass 16 
signatures. For instance, five unique and conserved biomarkers ions were identified in 17 
environmental E. coli isolates from avian but not from human sources (Siegrist, et al., 2007). 18 
Similarly, several Listeria monocytogenes serotypes could be separated using discriminating 19 
peaks (Barbuddhe, et al., 2008). 20 
Despite an increased level of complexity required for microbial subspecies classification, 21 
several published studies support the observation that MALDI-TOF MS represents a new 22 
promising technological approach for the classification of clinical and environmental isolates. 23 
Dieckmann et al. have successfully classified 126 isolates of Salmonella at the species and 24 
subspecies levels by optimizing a procedure that allowed them to obtain more than 300 25 
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biomarker peaks ranging from 2 to > 35 kDa (Dieckmann, et al., 2008). They found that out 1 
of three matrix mixtures, SA produced the most informative spectra by providing a significant 2 
increase of high molecular mass peaks with important subspecies specificity. In addition, 3 
simple clustering of mass data from bacterial fingerprints did not initially provide a clear 4 
discrimination of the strains at the subspecies level and a bioinformatic approach recently 5 
published by Teramoto et al. had to be used (Teramoto, et al., 2007). The approach is a new 6 
phylogenetic classification method based on ribosomal protein profiling by MALDI-TOF MS 7 
using the bioinformatics-based method for rapid identification of bacteria published by 8 
Demirev and co-workers (Demirev, et al., 1999). Using this approach, the result of the 9 
classification of several Pseudomonas putida strains including different biovars was in 10 
agreement with the gyrB gene sequences-based classification.  11 
The determination of serotypes of Shiga toxin-producing E. coli isolates has been achieved by 12 
constructing prototype spectra representing different serotype groups (Karger, et al., 2011). 13 
The prototype spectra were generated by removing masses with low discriminative 14 
significance, which is a process comparable to the generation of super-spectra proposed by 15 
the SARAMIS software. The generation of prototype spectra allowed a reduction of incorrect 16 
assignments down to 0.7% compared to the 31% incorrect assignments observed when 17 
unfiltered mass spectra were used. Unlike restriction fragment length polymorphism analysis, 18 
this analytical methodology could not achieve a differentiation below the serotype level.  19 
The typing of several microorganisms, such as Staphylococcus and Listeria species, for 20 
epidemiological studies require the use of various conventional techniques such as pulsed-21 
field gel electrophoresis (PFGE), amplified fragment length polymorphism analysis and 22 
multilocus sequence analysis (MLSA). These gold-standard techniques provide accurate 23 
classification of microorganism but suffer from important time and cost investments. For 24 
instance, only a few hours are required to obtain results by MALDI-TOF MS whereas several 25 
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days are necessary to collect PFGE data. In addition, these methods are technically relatively 1 
complex and have to be usually performed by experienced technicians.  2 
Several Staphylococcus studies have developed standardized methods to achieve reliable and 3 
reproducible species level identification and sub-typing from MALDI-TOF fingerprints 4 
(Edwards-Jones, et al., 2000, Walker, et al., 2002, Jackson, et al., 2005). When performed 5 
under careful experimental conditions, MALDI-TOF MS has been used to discriminate 6 
between methicillin-resistant (MRSA) and methicillin-susceptible S. aureus strains and to 7 
subtype MRSA strains. Thus, compared to conventional antimicrobial susceptibility test 8 
methods or gene sequencing techniques, these studies have demonstrated that MALDI-TOF 9 
MS represents a fast and cheap approach to accurately differentiate S. aureus strains. 10 
Unfortunately, no comparison of MALDI-TOF MS with PFGE has been done to demonstrate 11 
that these two methods would give similar results. However, Barbuddhe et al. have used 12 
MALDI-TOF to accurately identify 146 strains of different Listeria species and correctly 13 
classified all L. monocytogenes serotypes in agreement with PFGE, which is one of the most 14 
common subtyping technique used to classify L. monocytogenes serotypes (Barbuddhe, et al., 15 
2008). Similarly, Fujinami et al. have demonstrated that MALDI-TOF MS and PGFE gave 16 
similar accurate identification of epidemiologic Legionella strains (Fujinami, et al., 2010). 17 
Hazen et al. have demonstrated that MALDI-TOF MS could be used to discriminate between 18 
several Vibrio parahaemolyticus strains in replacement of PFGE or multilocus sequence 19 
analysis (MLSA) (Hazen, et al., 2009). Thus these studies showed that MALDI-TOF 20 
represents a new promising alternative approach to other demanding conventional methods 21 
such as PFGE and MLSA for microbial subtyping.  22 
Overall, the ultimate goal would be to use MALDI-TOF for a rapid prospective typing at the 23 
time of identification which should significantly benefit to hospital epidemiology and to 24 
infection control measures that have to be applied to prevent dissemination of pathogens. 25 
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Three recent studies have demonstrated that by applying subtle minor changes in the setup 1 
generally used in routine diagnostics, MALDI-TOF MS allowed a reproducible discrimination 2 
of major MRSA lineages (Wolters, et al., 2011), an identification of Salmonella enterica 3 
subsp. enterica serovars (Dieckmann & Malorny, 2011) and a differentiation between cfiA-4 
negative and cfiA-positive Bacteroidis fragilis isolates (Wybo, et al., 2011). These studies 5 
demonstrate that for several microbial species, minor changes in standardized procedures such 6 
as improved algorithm and user-friendly softwares applied in routine diagnostics will allow 7 
the use of MALDI-TOF MS for rapid and inexpensive microbial typing. This could 8 
significantly improve the approaches currently used to monitor epidemiological outbreaks and 9 
pathogens surveillance. 10 
Conclusion 11 
MALDI-TOF represents a very appealing new microbial identification technology that is 12 
efficient, rapid, cheap and easy of use. This explains why MALDI-TOF MS can be 13 
successfully used in clinical diagnostic laboratory for microbial identification starting from 14 
subcultures on agar plates and broth media but also directly from positive blood cultures and 15 
to a lesser extent from clinical samples such as urine. The application of MALDI-TOF at the 16 
subspecies level in typing is promising but still needs further improvement including 17 
instrument sensitivity, database quality and post-run analysis methods. Overall, a MALDI-18 
TOF MS will be soon present in most diagnostic laboratories since despite the significant cost 19 
of the instrument and for maintenance, running costs and consumables are much lower than 20 
those for other conventional methods rendering this technology a worthy quantum leap tool.  21 
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Tables 1 
Table 1. Performance of routine identification by MALDI-TOF MS.  2 
3 
References N Description Genus level 
(%) 
Species level 
(%) 
Mis-
identification
(%) 
No ID (%) Comments 
(van Veen, 
et al., 2010) 
327 
89 
55 
87 
77 
19 
Total 
Enterobacteriaceae  
Non-fermentative GN  
GP cocci  
Miscellaneous bacteria (HACCEK)  
Yeasts 
95.1 
100 
81.8 
97.7 
94.8 
100 
85.6 
96.6 
74.5 
80.5 
84.4 
94.7 
3 
3.4 
5.4 
1.1 
3.9 
0 
3.9 
0 
14.5 
2.3 
1.3 
0 
•Retrospective intra-laboratory study
•Misidentification: associated with absence or
mislabeling of reference spectra in the database
(van Veen, 
et al., 2010) 
980 
311 
88 
261 
165 
94 
61 
Total 
Enterobacteriaceae  
Non-fermentative GN  
GP cocci in cluster 
GP cocci in chains 
Enterococci 
Hemolytic streptococci 
Streptococcus milleri group 
Pneumococci 
Viridans streptococci 
Miscellaneous bacteria (HACCEK) 
Yeasts 
98.8 
100 
94.3 
100 
98.8 
100 
100 
100 
100 
90.5 
96.8 
96.7 
92 
97.7 
92 
94.3 
84.8 
98.4 
100 
77.8 
86.4 
9.5 
84 
85.2 
1.7 
0.3 
1.1 
0.4 
7.3 
0 
0 
0 
0 
57.1 
0 
3.3 
1.1 
0 
4.6 
0 
1.2 
0 
0 
0 
0 
9.5 
3.2 
3.2 
• Prospective intra-laboratory study
•Misidentification: associated with absence or
mislabeling of reference spectra in the database
•Viridans streptococci and pneumococci
characterized by many misidentifications.
•Weakness of the study: lack of sufficient
anaerobic bacteria and GP aerobic rods included
in the tested samples.
(Seng, et 
al., 2009) 
1660 
ND 
ND 
Total 
GP 
GN 
95.4 84.1 1.7 
0.8 
0.9 
2.8 
2 
0.7 
• Prospective intra-laboratory study
•Lack of identification mainly for non-
Clostridium anaerobes due to an absence of
reference spectra in the database
(Cherkaoui, 
et al., 2010) 
720 
416 
80 
111 
87 
6 
7 
Total 
Enterobacteriaceae  
Aerobic GN 
Staphylococci 
Aerobic GP 
Anaerobic GN 
Anaerobic GP 
100 94a / 89b 
99.8a / 95.9b 
97.5a / 96.3b 
98.2a / 96.4b 
73.6a / 55.2b 
17a / 0b 
57a / 43b 
0.9a / 0.5b 
0a / 0b 
1.25a / 0b 
0.9a / 0.9b 
3.4a / 2.3b 
0a / 0b 
25a / 0b 
•Comparative intra-laboratory study of two
commercial MALDI-TOF MS devices (Bruker
and Shimatzu)
•Bruker system a
• Shimatzu b
• Poor yield for streptococcal species and for GN
anaerobes (less than 50% correct identification).
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(Mellmann, 
et al., 2009) 
480 
60 
60 
60 
60 
60 
60 
60 
60 
Total 
Laboratory A 
Laboratory B 
Laboratory C 
Laboratory D 
Laboratory E 
Laboratory F 
Laboratory G 
Laboratory H 
98.7 
100 
96.67 
100 
93.33 
100 
100 
100 
100 
1.04 
0 
1.7 
0 
6.66 
0 
0 
0 
0 
0.2 
0 
1.7 
0 
0 
0 
0 
0 
0 
• Interlaboratory study
• 60 non-fermenting bacteria were shipped to 8
different laboratories with access to Bruker
platforms.
•No significant difference between direct
application and preprocessed samples
•Misidentification: sample interchange (4) and
skin contamination (1)
(Bizzini, et 
al., 2010) 
1371 
1371 
525 
525 
729 
729 
24 
24 
Total direct application 
Total protein extraction 
GP direct application 
GP protein extraction 
GN direct application 
GN protein extraction 
Yeasts direct application 
Yeasts protein extraction 
95.4 
99.6 
97 
100 
70.3 
92.6 
73.7 
98.85 
71.6 
92.2 
4.1 
100 
4.2 
0.95 
7 
0 
4.6 
0.4 
3 
0 
• Intra-laboratory study
• Protein extraction increases the total yield of
valid results by 25% compared to direct
application.
•Misidentification: inaccurate taxonomic
assignment, change in the taxonomy, limit of
resolution of the method.
(Marklein, 
et al., 2009) 
267 
267 
Total before complementation of 
database 
Total after complementation of the 
database 
92.5 
100 
7.5 
0 
• Intra-laboratory study of clinical yeast isolates
(Candida (n=250), Cryptococcus,
Saccharomyces, Trichosporon, Geotrichum,
Pichia and Blastoschizomyces spp.)
•All isolates identified upon complementation of
the database with appropriate reference strains.
•All samples were preprocessed with a protein
extraction step before deposition
(Bader, et 
al., 2010) 
1192 
1175a  / 
1152b 
Total 
Challenged against respective database 
97.6a /96.1b 
99a / 99.4b 
0.7a/ 0.2b 
0.5a / 0b 
1.7a / 3.7b 
0.5a / 0.6b 
•Comparative intra-laboratory study of two
commercial MALDI-TOF MS devices (Bruker
and Shimatzu) on clinical yeast isolates.
•Bruker system a
• Shimatzu b
•Better yield observed when the performance is
only tested on species present in respective
databases
•All sample were preprocessed with a protein
extraction step before deposition
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N, sample number. Genus and species level (%), percent of identification at the genus and species level respectively. Misidentification (%), percent of 1 
misidentified samples. No ID (%), percent of samples not identified. GP, Gram-positive. GN, Gram-negative.  2 
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1 
Table 2. Problems commonly found in routine identification by MALDI-TOF MS. 2 
Problems Examples 
Limit of resolution of the MALDI-TOF MS method • Shigella spp. identified as E. coli
Database discordances 
• Errors in the reference spectra
• Similarities of spectra present in the databasea
• Absence or insufficient reference spectra in the
databasea
• Propionibacterium acnes wrongly identified as Eubacterium brachy due to incorrect reference
spectra in the database
• Incomplete reference librairies for viridans streptococci and pneumococci.
• No reference of non-Clostridium anaerobes in the database.
• Insufficient number of reference spectra of Streptococcus pneumoniae and Streptococcus
parasanguinis in the database to differentiate accurately these two closely related species.
• Only 1 spectrum of Propionibacterium acnes or Bacillus cereus present in the database is not
enough to be representative of the true diversity of P. acnes and B. cereus profiles.
Taxonomical discordances • Stenotrophomonas maltophila misidentified as Pseudomonas hibiscicola, which is an invalid
name for S. maltophila
• Agrobacterium tumefaciens is synonymous of Rhizobium rhizogenes
Insufficient protein signal 
• Difficult to lyse cell wall structures
• Small amount of material sample
• Yeasts require a protein extraction procedure to be correctly identified.
• Pneumococci as well as most strains of Haemophilus influenzae and Klebsiella pneumoniae
possess a capsule which prevents efficient lysis and results to poor spectral quality.
• Actinomyces, Gemella, Nocardia and Streptomyces species usually display weak protein signals.
• Better signal for Enterobacteriaceae grown on blood agar versus Mc Conkey agar
3 
a
 A higher number of reference spectra in the database is usually required to accurately identify closely related microorganisms that display a high degree of 4 
spectrum similarities. Thus, these two parameters are interdependent. 5 
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1 
Table 3. Performance of MALDI-TOF identification obtained from positive blood culture. 2 
Reference Sample 
(n) 
Blood culture 
system 
Concordant 
identification 
to species level 
Concordant 
identification 
to genus level 
Identification 
difficulty 
Comments 
(Prod'hom, et al., 2010) 126 positive blood 
culture (Bactec) 
78%,  
GN: 89%,  
GP: 72% 
79%,  
GN: 89%,  
GP: 73% 
Streptococcus mitis 
group, Staphylococcus 
spp. 
Use of ammonium chloride to lyse 
erythrocyte. 
The presence of a capsule explain 
partially the low identification rate 
of S. pneumoniae, H. influenzae, K. 
pneumoniae 
(La Scola & Raoult, 2009) 599 positive blood 
culture (Bactec) 
66% 
GN : 91% 
GP : 49% 
66% Streptococcus spp., 
polymicrobial samples 
During the study, modification of 
the extraction protocol to improve 
Staphylococci identification (38% -
>75%). 
(Stevenson, et al., 2010) 212 positive blood 
culture (179),  
spiked bottles 
(33) (Bactec) 
80% 80% Streptococcus mitis 
group, 
Propionobacterium 
acnes 
Use of a separator device for blood 
cells removal. 
(Ferroni, et al., 2010) 685 positive blood 
culture (388),  
spiked bottles 
(312) 
89% 98% Streptococcus 
pneumoniae, 
Streptococcus mitis 
group, 
polymicrobial samples 
Use of saponin to lyse erythrocyte. 
(Christner, et al., 2010) 277 positive blood 
culture (Bactec) 
94% 95% Cocci GP Mismatch mostly resulted from 
insufficient bacterial quantity and 
occurred preferentially with GP 
bacteria 
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(Ferreira, et al., 2010) 300 positive blood 
culture (Bactec) 
43%, 
GN: 83%, 
GP: 32% 
72%, 
GN: 97%, 
GP: 66% 
Streptococcus mutans, 
Staphylococcus spp., 
Staphylococcus aureus 
No mixed culture 
(Ferreira, et al., 2010) 68 positive blood 
culture (Bactec) 
76% 
ICM 47% 
PEM 76% 
96% 
ICM 51% 
PEM 93% 
Staphylococcus spp. PEM improve the identification 
compared to ICM 
(Marinach-Patrice, et al., 
2010) 
48 spiked bottles 
with Candida 
(Bactec) 
100% 100% Use of SDS as detergent to lyse 
erythrocytes.  
Application of a new algorithm's 
concept since residual blood 
proteins and Candida share many 
masses in common. 
(Szabados, et al., 2011) 268 positive blood 
culture 
(BacT/ALERT)  
(non charcoal 
containing 
bottles) 
31% ND Polymicrobial samples In a preliminary study, a lower rate 
of identification with charcoal-
containing bottle was observed 
(8%).  
(Romero-Gomez & 
Mingorance, 2011) 
129 positive blood 
culture  
Bactec (42) 
Versatrek (35) 
BacT/ALERT 
(52) 
68% 
76% (Bactec) 
69% 
(Versatrek) 
62% 
(BacT/Alert) 
ND Significant lower 
performance for GP 
bacteria 
1 
Adapted from Carbonelle 2010, (Carbonnelle, et al., 2010), GN: Gram-negative bacteria, GP: Gram-positive bacteria, ICM: intact cell method, PEM: protein 2 
extraction method, SDS: Sodium Dodecyl Sulfate, ND: not determined. 3 
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Figure legends 1 
Figure 1. Technical description of MALDI-TOF MS. The sample is mixed with a matrix on a 2 
conductive metal plate. After crystallisation of the matrix and microbial material, the metal 3 
plate is introduced in the mass spectrometer and is bombarded with brief laser pulses. The 4 
desorbed and ionized molecules are accelerated through an electrostatic field and ejected 5 
through a metal flight tube subjected to vacuum until they reach a detector, with smaller ions 6 
travelling faster than larger ions. Thus, bioanalytes separated according to their time of flight 7 
(TOF) create a mass spectrum that is composed by mass to charge ratio (m/z) peaks with 8 
varying intensities. A spectrum is thus a microbial signature that is compared to a database for 9 
the identification at the species or genus level.  10 
Figure 2. Intra-laboratory reproducibility tested by measuring the number of conserved peaks 11 
in two experimental settings. In the first setting, ethanol/formic acid extraction was applied on 12 
E. coli ATCC 25922 (A) or S. aureus ATCC 25923 (B) and 10 replicates of one extraction 13 
were spotted onto the MALDI-TOF microplate (1µl, about 106 bacteria/µl). In the second 14 
setting, 10 independent extractions were done and one replicate of each extraction was spotted 15 
onto the MALDI-TOF microplate. After smoothing and baseline subtraction, the 100 highest 16 
peaks from each spot were selected and the number of time a given peak is present out of 10 17 
times was determined for each peak in the two different settings for E. coli and S. aureus. 18 
Figure 3. The amount of material is a critical factor for accurate microbial identification by 19 
MALDI-TOF MS. (A) Spectral fingerprints obtained from various quantities (106 to 103) of E.20 
coli ATCC 25922 grown on blood agar plates. The inoculums were prepared from a sample 21 
with a turbidity of 4.0 McFarland that was diluted to obtain the approximate quantity used for 22 
direct microplate deposition (106 to 103 bacteria per spot). Protein extraction was performed 23 
by directly mixing the samples with formic acid on microplate. The results show that the 24 
quality of the spectrum and thus the performance of identification are largely dependent on 25 
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the sample amount spotted on the microplate. (B) Growth of Staphylococcus epidermidis on 1 
blood agar plates at 35°C in 5% CO2 atmosphere after an incubation of 2, 4, 6, 8 hours, 2 
respectively. Usually, at least 6 hours incubation are required to get sufficient amount of 3 
material to obtain an efficient MALDI-TOF MS identification (C) Cumulative percentage of 4 
MALDI-TOF identification obtained from Gram-negative (Escherichia coli (13), 5 
Pseudomonas putida (2), Klebsiella pneumoniae (2), Enterobacter cloacae (1)) and Gram-6 
positive (Staphylococcus epidermidis (13), Staphylococcus aureus (9), Streptococcus 7 
pyogenes (4), Streptococcus pneumoniae (1), Staphylococcus hominis (1)) bacteria after 8 
short-time plating on agar during 2, 4, 6, 8 hours, respectively. The number of samples for 9 
each bacterial species analysed is indicated in brackets. 10 
Figure 4. Importance of the organization of a working day to optimize time to results. Each 11 
line represents a MALDI-TOF run, with the waiting time for equipment availability, the time 12 
required to prepare the target layout and the time of the MALDI-TOF running process. In this 13 
example of a working day, eight MALDI-TOF target plates have been used to analyse 14 
multiple clinical samples (ICU, S: intensive care unit and surgery (1 run); IM, P: internal 15 
medicine, pediatry and others (1 target plate); BC: blood cultures (4 runs); U: urine (2 runs)). 16 
Urgent samples such as blood cultures are directly processed while colonies identification 17 
from agar cultures are processed by batch. The processing of the samples is organized to 18 
guarantee the optimal use of the MALDI-TOF device during the working day. 19 
Figure 5. E. coli identification yield in urine samples. Five ml of urine samples positive by 20 
microscopy were centrifuged to concentrate and collect the bacteria. The pellet was 21 
resuspended in 200µl water and subjected to protein extraction with ethanol and formic acid 22 
prior deposition on the microplate. The graph shows the identification yield according to the 23 
bacterial load per ml. 24 
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Figure 6. Importance of the maintenance and quality controls of the MALDI-TOF device 1 
demonstrated by a follow-up of the temporal reproducibility. (A) Spectral fingerprint of S. 2 
aureus quality controls during a 10 weeks control period. (B) Percentage of conserved peaks 3 
during a 10 weeks control period. E. coli and S. aureus quality controls fingerprints were 4 
compared to a set of conserved peaks (81 and 80 respectively). The poor performance 5 
observed during week 1 to 3 was likely caused by a problem of inadequate sample deposition 6 
on the MALDI-TOF MS microplates. 7 
Figure 7. Quality control for MALDI-TOF mass spectrometry. (A) Presence of residual 8 
materials on some wells (especially C4, E3 and E4, indicated by white arrows) of a MALDI-9 
TOF micropalte after a routine wash, highlighting the importance of careful wash after each 10 
usage; (B) mass spectra obtained with the Bruker BST control, that consists in lyophilized E. 11 
coli spiked with RNAse A (black arrow at a m/z of 13683) and myoglobin (white arrow at a 12 
m/z of 16952); in the lower part of the panel, the list of the eight  proteins that should be 13 
present to validate the run and their expected and observed m/z values.  14 
15 
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Supplementary materials. 1 
2 
Box S1. 3 
Hardwares and Softwares 4 
To date, mainly two MALDI-TOF MS instruments, commercialized by Bruker Daltonics 5 
(Bruker Daltonik GmbH, Bremen, Germany) and Shimadzu (Shimadzu Corporation, Kyoto, 6 
Japan), are available for routine microbiology. The two companies have different data 7 
analysis solutions to process raw MALDI-TOF spectra and to compare this data with spectra 8 
of reference libraries. The Bruker instrument provides its own software package, the MALDI 9 
Biotyper (Bruker Daltonik GmbH, Bremen, Germany), which includes software and database. 10 
The Shimadzu instrument provides the Shimadzu Launchpad software and uses the 11 
SARAMIS database (Spectral Archiving and Microbial Identification System, AnagnosTec 12 
GmbH, Germany). Both software packages allow processing of raw data (baseline 13 
substraction, smoothing, and normalization) and comparison of the processed data to a built-14 
in reference library. The reliability of this technology largely depends on the reference 15 
database and the algorithm used for spectral comparison. 16 
The BioTyper reference library currently contains reference spectra for more than 3200 17 
reference strains (Nagy, et al., 2009) and reference spectra for newly investigated bacteria can 18 
be added to the reference library (Barbuddhe, et al., 2008, Mellmann, et al., 2008). The 19 
library spectra are generated by multiple measurements (average of 20 measured spectra) of 20 
known bacterial isolates under slightly different conditions to extract specific peak 21 
information. The software automatically generates peak lists from the whole set of spectra and 22 
extracts typical peaks which are present in a certain number of spectra from one species. 23 
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The SARAMIS database contains over 62,500 single fingerprint spectra of different isolates 1 
representing more than 1,160 species, 233 genera and 2,700 super-spectra. Indeed, the 2 
SARAMIS database contains two types of spectra: super-spectra and reference spectra. Super-3 
spectra are consensus spectra of multiple mass spectra of reference strains of individual 4 
serotypes, species or genera, respectively. A super-spectrum can thus be considered as a 5 
reference peak signature of multiple isolates of a species that include a subset of characteristic 6 
and reproducible markers (typically 15). The concept of super-spectra has been developed to 7 
cope with the natural diversity found in all microbial species which can results in variation of 8 
the peaks pattern. The SARAMIS database contains nowadays about 2,700 super-spectra 9 
corresponding to 900 different microbial species. Since by definition super-spectra represent 10 
the most typical isolates of a species, some less frequent isolates of a given species will not be 11 
detected in routine analysis and are then processed using a second-line identification process 12 
through a direct comparison to all reference spectra present in the database. 13 
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Table S1. Summarized characteristics of several types of mass analysers.1 
Mass analyser Advantages Disadvantages 
Time of flight 
(TOF) 
• Unlimited mass range (m/z)
• Good mass accuracy and resolution
• Simplest mass analyser. Compact and easy to
manipulate instrument.
• Easily adapted to MALDI.
• Low cost.
• Less adapted to ESI than MALDI.
Fourier transform 
ion cyclotron 
resonance (FTICR) 
• High mass range, up to 10’000 m/z
• Excellent mass accuracy and resolution.
• Easily adapted to MALDI and ESI
• Well suited to analyse complex mixtures
•Expensive, require superconducting
magnet.
Quadrupole • Easily adapted to ESI
• Low cost
• Small size
• Ease to switch between positive and negative ions
•Limited mass range, up to 3000-4000
m/z
•Relative low mass accuracy and
resolution. Sensitivity and resolution are
opposed using quadrupole analysers.
• Poor adaptability to MALDI
Ion trap • Easily adapted to MALDI and ESI
• Excellent sensitivity
• Ease to switch between positive and negative ions
• Low cost
• Small size. Simple design.
•Limited mass range, up to 3000-4000
m/z
•Relative low mass accuracy and
resolution.
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Table S2. Costs savings thank to MALDI-TOF MS by reduced need of conventional identification methods. Data derived from a 4 weeks study 1 
done in our laboratory, during which a total of 1214 microbial isolates were correctly identified at the species level by MALDI-TOF MS. These 2 
costs savings observed on a 4 weeks period were used to estimate the annual costs reduction. 3 
Reagents Identification Number Price/test 
(€) 
Total (4 weeks) 
(€) 
Total (extrapolation 1 year) 
(€) 
Vitek GN ID card  Gram-negative bacteria 270 6.8 1836 23868 
Vitek GP ID card  Gram-positive bacteria 146 6.1 890 11570 
Rapid ID 32E Enterobacteriaceae 16 5.3 84.8 1102.4 
API NH Neisseria and 
Haemophilus spp. 
11 7.6 83.6 1086.8 
Rapid ID 32 Strep Streptococci 8 5.3 42.4 551.2 
Vitek YST ID card Yeasts 8 6.1 48.8 634.4 
Rapid ID 32A Anaerobes 1 5.3 5.3 68.9 
Api coryne Corynebacterium spp. 1 8.3 8.3 107.9 
ID 32C Yeasts 1 5.3 5.3 68.9 
Total: 3004.5 Total: 39058.5 
4 
€, Euro. The prices were converted from Swiss Francs (CHF) to Euros according to the exchange rate of the 19th of April 2011.  5 
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Figure S1. Maintenance of MALDI-TOF mass spectrometer: (A) The MALDI-TOF 1 
apparatus prior to disassembly. (B) The MALDI-TOF apparatus is completely opened during 2 
maintenance to allow inspection and cleaning. (C) Please note the presence of dust particles in 3 
the inner part of the MALDI-TOF mass spectrometer (arrow n° 1). (D) Dust may prevent 4 
optimal tightness of the plastic joint (arrow n° 2) and this may lead to imperfect vacuum; 5 
please note the presence of trace of carbonization at the entry of the acceleration tube (arrow 6 
n° 3). 7 
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Figure 1. Technical description of MALDI-TOF MS. The sample is mixed with a matrix on a 
conductive metal plate. After crystallisation of the matrix and microbial material, the metal plate 
is introduced in the mass spectrometer and is bombarded with brief laser pulses. The desorbed 
and ionized molecules are accelerated through an electrostatic field and ejected through a metal 
flight tube subjected to vacuum until they reach a detector, with smaller ions travelling faster 
than larger ions. Thus, bioanalytes separated according to their time of flight (TOF) create a mass 
spectrum that is composed by mass to charge ratio (m/z) peaks with varying intensities. A 
spectrum is thus a microbial signature that is compared to a database for the identification at the 
species or genus level.  
192x289mm (300 x 300 DPI)  
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Figure 2. Intra-laboratory reproducibility tested by measuring the number of conserved peaks in 
two experimental settings. In the first setting, ethanol/formic acid extraction was applied on E. coli 
ATCC 25922 (A) or S. aureus ATCC 25923 (B) and 10 replicates of one extraction were spotted onto 
the MALDI-TOF microplate (1l, about 106 bacteria/ l). In the second setting, 10 independent 
extractions were done and one replicate of each extraction was spotted onto the MALDI-TOF 
microplate. After smoothing and baseline subtraction, the 100 highest peaks from each spot were 
selected and the number of time a given peak is present out of 10 times was determined for each 
peak in the two different settings for E. coli and S. aureus.  
166x335mm (300 x 300 DPI)  
Page 67 of 73
ScholarOne Support 1-434/964-4100
FEMS Microbiology Reviews
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Figure 3. The amount of material is a critical factor for accurate microbial identification by MALDI-
TOF MS. (A) Spectral fingerprints obtained from various quantities (106 to 103) of E. coli ATCC 
25922 grown on blood agar plates. The inoculums were prepared from a sample with a turbidity of 
4.0 McFarland that was diluted to obtain the approximate quantity used for direct microplate 
deposition (106 to 103 bacteria per spot). Protein extraction was performed by directly mixing the 
samples with formic acid on microplate. The results show that the quality of the spectrum and thus 
the performance of identification are largely dependent on the sample amount spotted on the 
microplate. (B) Growth of Staphylococcus epidermidis on blood agar plates at 35°C in 5% CO2 
atmosphere after an incubation of 2, 4, 6, 8 hours, respectively. Usually, at least 6 hours incubation 
are required to get sufficient amount of material to obtain an efficient MALDI-TOF MS identification 
(C) Cumulative percentage of MALDI-TOF identification obtained from Gram-negative (Escherichia 
coli (13), Pseudomonas putida (2), Klebsiella pneumoniae (2), Enterobacter cloacae (1)) and Gram-
positive (Staphylococcus epidermidis (13), Staphylococcus aureus (9), Streptococcus pyogenes (4), 
Streptococcus 
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pneumoniae (1), Staphylococcus hominis (1)) bacteria after short-time plating on agar during 2, 4, 
6, 8 hours, respectively. The number of samples for each bacterial species analysed is indicated in 
brackets.  
200x338mm (300 x 300 DPI)  
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Figure 4. Importance of the organization of a working day to optimize time to results. Each line 
represents a MALDI-TOF run, with the waiting time for equipment availability, the time required to 
prepare the target layout and the time of the MALDI-TOF running process. In this example of a 
working day, eight MALDI-TOF target plates have been used to analyse multiple clinical samples 
(ICU, S: intensive care unit and surgery (1 run); IM, P: internal medicine, pediatry and others (1 
target plate); BC: blood cultures (4 runs); U: urine (2 runs)). Urgent samples such as blood 
cultures are directly processed while colonies identification from agar cultures are processed by 
batch. The processing of the samples is organized to guarantee the optimal use of the MALDI-TOF 
device during the working day.  
89x48mm (300 x 300 DPI)  
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Figure 5. E. coli identification yield in urine samples. Five ml of urine samples positive by 
microscopy were centrifuged to concentrate and collect the bacteria. The pellet was resuspended 
in 200µl water and subjected to protein extraction with ethanol and formic acid prior deposition on 
the microplate. The graph shows the identification yield according to the bacterial load per ml.  
95x82mm (300 x 300 DPI)  
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Figure 6. Importance of the maintenance and quality controls of the MALDI-TOF device 
demonstrated by a follow-up of the temporal reproducibility. (A) Spectral fingerprint of S. aureus 
quality controls during a 10 weeks control period. (B) Percentage of conserved peaks during a 10 
weeks control period. E. coli and S. aureus quality controls fingerprints were compared to a set of 
conserved peaks (81 and 80 respectively). The poor performance observed during week 1 to 3 was 
likely caused by a problem of inadequate sample deposition on the MALDI-TOF MS microplates.  
229x334mm (300 x 300 DPI)  
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Figure 7. Quality control for MALDI-TOF mass spectrometry. (A) Presence of residual materials on 
some wells (especially C4, E3 and E4, indicated by white arrows) of a MALDI-TOF micropalte after a 
routine wash, highlighting the importance of careful wash after each usage; (B) mass spectra 
obtained with the Bruker BST control, that consists in lyophilized E. coli spiked with RNAse A (black 
arrow at a m/z of 13683) and myoglobin (white arrow at a m/z of 16952); in the lower part of the 
panel, the list of the eight  proteins that should be present to validate the run and their expected 
and observed m/z values.  
169x269mm (300 x 300 DPI)  
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Figure S1.Maintenance of MALDI-TOF mass spectrometer: (A) The MALDI-TOF apparatus prior to 
disassembly. (B) The MALDI-TOF apparatus is completely opened during maintenance to allow 
inspection and cleaning. (C) Please note the presence of dust particles in the inner part of the 
MALDI-TOF mass spectrometer (arrow n° 1). (D) Dust may prevent optimal tightness of the plastic 
joint (arrow n° 2) and this may lead to imperfect vacuum; please note the presence of trace of 
carbonization at the entry of the acceleration tube (arrow n° 3).  
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